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Abstract 
DNA alkylation damage, emanating from the exposure to environmental alkylating 
agents or produced by certain endogenous metabolic processes, affects cell viability 
and genomic stability. Fe(II)/2-oxoglutarate-dependent dioxygenase enzymes, such 
as Escherichia coli (E coli) AlkB is involved in protecting DNA from alkylation 
damage. Previous studies have shown that AlkB preferentially removes alkyl DNA 
adducts from single-stranded DNA (ssDNA). Notably, ssDNA produced during 
DNA replication and recombination, remains bound to E. coli single-stranded DNA 
binding protein SSB and it is not known whether AlkB can repair methyl adduct 
present in SSB-coated DNA. Therefore, AlkB-mediated DNA repair using SSB-
bound DNA as substrate is studied in the present thesis. By using in vitro repair 
reaction, it is found that AlkB can efficiently remove N3-methyl Cytosine (N3meC) 
adducts inasmuch as DNA length is shorter than 20 nucleotides. However, when 
longer N3meC-containing oligonuleotides were used as the substrate, efficiency of 
AlkB catalyzed reaction is found to be abated compared to SSB-bound DNA 
substrate of identical length. It is also observed here that truncated SSB containing 
only the DNA binding domain can support the stimulation of AlkB activity, 
suggesting the importance of SSB-DNA interaction for AlkB function. Using 70-
mer oligonucleotide containing single N3meC, it is demonstrated that SSB-AlkB 
interaction promotes faster repair of the methyl DNA adducts.  
Intrinsically disordered regions (IDRs) of proteins often regulate function 
through interactions with folded domains. E. coli single-stranded DNA binding 
protein SSB binds and stabilizes ssDNA. The N-terminal of SSB contains 
characteristic oligonucleotide/oligosaccharide-binding (OB) fold which binds 
ssDNA tightly but non-specifically. SSB also forms complexes with large number 
proteins via the C-terminal interaction domain consisting mostly of acidic amino 
xi 
 
acid residues. The amino acid residues located between the OB-fold and C-terminal 
acidic domain are known to constitute an intrinsically disordered region (IDR) and 
no functional significance has been attributed to this region. Although SSB is known 
to bind many DNA repair protein, it is not known whether it binds to DNA 
dealkylation repair protein AlkB. Therefore, AlkB-SSB interaction is characterized 
in detail in this thesis. It is demonstrated by in vitro pull-down and yeast two-hybrid 
analysis that SSB binds to AlkB via the IDR. The site of contact is found to be the 
residues 152-169 of SSB. The present study also reveals that unlike most of the 
SSB-binding proteins which utilize C-terminal acidic domain for interaction, IDR of 
SSB is necessary and sufficient for AlkB interaction.  
The human homologue of AlkB, AlkB homologue 3 (AlkBH3), is also a 
member of the dioxygenase family of enzymes involved in DNA dealkylation repair. 
Because of its role in promoting tumor cell proliferation and metastasis of cancer, 
extensive efforts are being directed in developing selective inhibitors for AlkBH3. 
The present thesis also reports screening and evaluation of panel of arylated 
indenone derivatives as new class of inhibitors of AlkB and AlkBH3 DNA repair 
activity. The indenone-derived AlkB and AlkBH3 inhibitors are found to display 
specific binding and competitive mode of inhibition. It is demonstrated that AlkB 
inhibitor has the ability to sensitize cells to methyl methane sulfonate (MMS) that 
mainly produce DNA alkylation damage and AlkBH3 inhibitor can prevent the 
proliferation of lung cancer cell line and enhance sensitivity to MMS. 
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Introduction 
Exposure to environmental or endogenous alkylating agents induces DNA alkylation 
damages that are known to affect genomic stability, cellular viability and cause 
multiple diseases such as cancer and aging. Alkylating agents from the environment 
such as tobacco-specific nitrosamines and chemotherapeutic drugs or endogenous 
alkylating agents such as S-adenosylmethionine (SAM) can form cytotoxic or 
mutagenic lesions. DNA damaging alkylating agents are divided into two categories 
based on the mechanism of alkylation reaction. SN1 type alkylating agents such as 
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) act indirectly by forming a 
carbocation intermediate and generates mutagenic lesion on both nitrogen and 
oxygen in DNA such as O
6
-methylguanine and cytotoxic N
3
-methyladenine. SN2 
type alkylating agents, such as Methyl methanesulfonate (MMS) act directly and 
produces alkyl adducts predominantly at DNA base nitrogens such as N
1
-
methyladenine (1meA) and N
3
-methylcytosine (3meC).  N-alkylated DNA adducts 
m1A and 3meC in single stranded DNA and RNA are repaired by Escherichia coli 
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AlkB which belongs to the family of iron (Fe II) and 2-oxoglutarate-dependent 
dioxygenases. AlkB catalyzed demethylation reaction is coupled to the oxidative 
decarboxylation of 2-oxoglutarate (-ketoglutarate) to succinate and CO2 resulting 
in hydroxylation of methyl group. The hydroxymethyl group is unstable and 
spontaneously released as formaldehyde restoring 1meA and 3meC (Figure 1).  
 
 
 
 
 
Figure 1. DNA repair reaction catalyzed by AlkB family of enzymes 
 
AlkB preferentially repairs methyl adducts from single stranded DNA. Bacterial 
single stranded DNA (ssDNA) regions are usually stabilized by binding to single 
stranded DNA binding protein (SSB.) E. coli SSB is a tetrameric protein and each 
monomer has two domains: the characteristic OB-domain 
(Oligonucleotide/oligosaccharide Binding) that binds ssDNA and structurally 
disordered C-terminal domain (CTD). CTD of SSB is known to bind several 
proteins involved in DNA repair, recombination and replication. The CTD is 
subdivided into two regions the intrinsically disordered linker region (IDL) and the 
acidic tip formed by last 8-10 amino acids. The acidic tip is conserved whereas IDL 
has low sequence complexity and is enriched with a large number of proline, 
glycine, and glutamine residues. The acidic tip was considered to be essential for 
protein-protein interaction but recent reports have shown that the linker region also 
facilitates SSB interaction with other proteins. Homologues of AlkB have been 
identified across the species from bacteria to mammals and has eight human 
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homologues (AlkBH1-8). AlkB and its homologues share a common structural 
feature, known as double-stranded β-helical (DSBH) fold or jelly-roll fold, 
composed of eight β-strands that form two four-stranded antiparallel β-sheets. This 
DSBH fold contains conserved sequence motif HXD/E(X)nH for metal binding. 
AlkB homologue-3 (AlkBH3), like AlkB, preferentially repairs m1A and 3meC base 
lesions in ssDNA and RNA.  
The present work entitled as “Functional characterization of DNA 
dealkylation repair protein AlkB from Escherichia coli and use of indenone 
derivatives as inhibitors of AlkB and human AlkB homologue 3 (AlkBH3)” has 
been divided into 5 chapters. Chapter 1 is General Introduction and focuses on the 
background of the study and review of the literature. Chapters 2-5 have three 
sections, namely Introduction, Materials and Methods and Results and Discussions. 
Overall, this thesis deals with the biochemical and functional characterization of 
DNA repair protein AlkB.  It describes how DNA repair reaction was reconstituted 
in vitro and experiments were carried out to determine its mode of action, especially 
with respect to the varying length of the substrate. The study also investigates 
AlkB’s affinity towards SSB and identifies a novel interaction domain on SSB. The 
present work also elaborates indenone derivatives as a new class of inhibitors 
against AlkB and AlkBH3. The mechanisms of inhibition, mode of binding and 
cellular effect were studied extensively. 
Chapter 1 is the General Introduction which embodies the brief review of 
the literature dedicated to the AlkB and its human homologue AlkBH3 and their 
structural features. It mainly describes how substrate specificity of AlkB family of 
enzymes is regulated. Since AlkB preferentially repairs ssDNA, it also encounters 
SSB which wraps the ssDNA. Chapter 1 also reviews recent literature on SSB and 
its interaction partners. The chapter also focuses on AlkB and AlkBH3 inhibitors 
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reported so far. Based on the structural studies of AlkB and AlkBH3 docking 
analysis were performed with all the inhibitors reported in the literature to analyze 
the mode of binding. The chapter also reviews the literature on the mechanism of 
inhibition, binding affinity and cellular effects of AlkB and AlkBH3 inhibitors. 
The significance of the work has been elaborated in this chapter. AlkBH3 has 
been extensively studied for its role in promoting tumour cell proliferation and 
metastasis of cancer. Several studies have shown a high level of AlkBH3 expression 
in non–small-cell lung cancer, prostate cancer, pancreatic cancer and renal cell 
carcinoma. Knockdown of AlkBH3 in these cells resulted in reduced proliferation. 
Extensive efforts are being made for developing selective inhibitors for AlkBH3 as 
therapeutically desirable lead molecules. AlkBH3 inhibitors can be potentially used 
in combination therapy with chemotherapy agents allowing a reduction in the 
amount of cytotoxic alkylating agents used in cancer chemotherapy. 
Chapter 2 describes functional characterization of E. coli DNA 
dealkylation repair protein AlkB. The objectives of this chapter were to 
characterize DNA-demethylation activity of AlkB with substrates of different 
lengths and determine the role of SSB in the AlkB-mediated repair of ssDNA 
substrate. Most of the studies on AlkB activity have analyzed short oligonucleotide 
substrates or long stretches of ssDNA in a protein-free environment. Since ssDNA 
generated during DNA replication or repair always remains bound by SSB, SSB-
bound ssDNA was studied in this chapter to characterize AlkB activity. In order to 
study the demethylation activity of AlkB, oligonucleotides of varying lengths 10-
70mer containing single 3meC were used as substrates. Demethylation activity was 
determined by direct repair assay where the formaldehyde released reacts with 
acetoacetanillide and ammonia forming a fluorescent compound with emission at 
465 nm. It was observed that the AlkB can efficiently repair the shorter 
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oligonucleotide substrates (10mer oligonucleotides), but the repair activity was 
diminished for longer substrate (70mer oligonucleotides). However, when the 
complex of longer oligonucleotide DNA bound by SSB was used as a substrate in 
AlkB demethylation reaction, the repair activity was efficient. It was also observed 
that the presence or absence of SSB did not alter the AlkB demethylation activity 
with shorter length substrates. These observations were consistent with the previous 
reports, which showed that ssDNA shorter than 20 nucleotides failed to bind SSB.  
To mimic the cellular conditions, the repair reaction was also reconstituted with 
MMS damaged M13 DNA having numerous randomly located methyl adducts as a 
substrate for AlkB. When the repair activity was monitored in the presence and 
absence of SSB, it was found that AlkB activity was significantly higher with SSB 
bound M13 DNA compared to the free M13 DNA. These results were further 
confirmed by another method wherein formaldehyde generation was detected via the 
activity of Formaldehyde dehydrogenase (FDH). In order to examine whether SSB-
DNA interaction is required for stimulation of AlkB activity, C-terminal truncated 
SSB having only DNA binding domain was used to form SSB-DNA complex. This 
complex was then used as substrate for AlkB repair reaction. It was found that the 
truncated SSB could also facilitate the repair activity of AlkB. To further explore the 
mechanism of stimulation of AlkB mediated DNA repair by SSB, kinetics of AlkB 
catalyzed reaction using 70-mer substrate was studied.  Two different 70mer 
substrates were used to study kinetics, one having single me3C positioned at the 
terminal and the other having internally located me3C. It was observed that the 
presence of SSB was dispensable for terminally located methyl adduct repair and no 
change in kinetic parameters was observed. However, for the internally located 
damaged residue, it was observed that AlkB was able to repair but with a higher KM. 
Addition of SSB significantly stimulated the repair activity and KM was reduced 
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considerably. From these studies, it was concluded that as the length of the ssDNA 
increases, the catalytic efficiency of AlkB decreases. Since the longer stretch of 
ssDNA is always bound by SSB, AlkB readily repairs such SSB-bound DNA 
Chapter 3 focuses on the interaction of AlkB with SSB. The objective of 
this chapter was to characterize the protein-protein interaction between AlkB and 
SSB. Several sequential deletion constructs of SSB were generated to study AlkB-
SSB interaction by the yeast-two-hybrid assay. The direct interactions of proteins 
were investigated by expression of the reporter genes HIS3 and lacZ. It was 
observed that the C-terminal domain of SSB interacts directly with AlkB. The site of 
interaction was mapped between amino acid residues 152–169 of SSB located in the 
intrinsically disordered linker region. To verify the results of the yeast-two-hybrid 
assay, SSB-AlkB interaction was studied using in-vitro GST pull-down assay. The 
results showed that his-tagged AlkB protein was bound to GST-SSB and the site of 
interaction was found to be amino acid residues 152–169 of SSB belonging to the 
IDL region. The strength of SSB-AlkB interaction was then studied in presence of 
increasing ionic strength. It was observed that the interaction of AlkB and SSB was 
lost at high NaCl concentrations. It was also observed that there is week interaction 
between AlkB and SSB. Based on the conclusion from chapter 1, this interaction 
was also studied in the presence of ssDNA. It was observed that AlkB-SSB 
interaction was more resistant to high salt NaCl concentrations in presence of DNA 
suggesting that the presence of ssDNA renders stability to SSB-AlkB complex. To 
gain further insight into AlkB-SSB interaction, the effect of NaCl was studied on 
conformation of AlkB and SSB. By CD spectra analysis of SSB it was observed that 
it remains unchanged at a high salt concentration in agreement with the published 
reports. The CD spectra analysis of AlkB at lower and higher salt concentrations 
showed very little conformational change. To further determine the strength of the 
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interaction between residues 152–169 of SSB and AlkB, thermodynamic parameters 
were measured by ITC. The synthetic SSB peptide used for ITC was first analyzed 
by CD spectroscopy to confirm the conformation of the peptide. It was observed that 
AlkB binds to the SSB peptide weekly with a micromolar dissociation constant.  
Chapter 4 describes Screening and evaluation of indenone derivatives as 
AlkB inhibitors. The objective of this chapter was to screen and evaluate a library 
of 17 indenone derivatives for their potential AlkB inhibition property. The library 
of indenone derivatives was synthesized in collaboration with Prof. Faiz Ahmed 
Khan’s research group, Department of chemistry, IIT Hyderabad. The indenone 
compounds were screened using direct repair assay where the formaldehyde release 
was monitored using purified recombinant AlkB. 40 mer oligonucleotide containing 
single 3meC was used as a substrate. It was found that a compound 3o was able to 
inhibit AlkB activity significantly and the activity of human AlkBH3 remained 
unaltered in presence of 3o, suggesting the specificity of 3o to AlkB. The binding 
affinity of compound 3o with respect to AlkB was evaluated using ITC. The ITC 
data revealed the binding between 3o and AlkB to be tight with dissociation constant 
3.3 µM.   The complex formation between AlkB and compound 3o was also 
evaluated using CD spectra analysis to find out if there is any local energy change in 
the overall conformation of AlkB upon 3o binding. The results indicated slight 
alterations in the helical content and an alteration of characteristic double-stranded 
-helix conformation of AlkB when bound to 3o. The mechanism of inhibition of 
AlkB by 3o was determined by studying the steady-state enzyme kinetics of AlkB in 
presence of 3o. For this, the initial velocities of AlkB was were determined and 
fitted to double-reciprocal Lineweaver-Burk plot. No change in Vmax was observed 
in the presence of 3o, indicating a competitive mode of inhibition for the DNA 
substrate. The mode of inhibition with respect to co-substrate 2OG was found to be 
xix 
 
a mixed type of inhibition. We further analyzed the binding conformation of 3o 
using molecular docking. Docking study showed that 3o interacted with the DNA 
binding residues of AlkB presumably occupying the DNA binding pocket and 
blocking AlkB-DNA interaction. To examine whether the compound 3o can inhibit 
E coli AlkB function in vivo, the proliferation of E. coli cells was studied in the 
presence of compound 3o and MMS. It was observed that growth of wild-type E. 
coli was more affected by the presence of MMS and 3o than in the presence of 
MMS alone. The study in this chapter revealed compounds 3o to be competitive 
inhibitors of AlkB-catalyzed demethylation of DNA. This compound exhibited 
selective binding properties and able to modulate the function of AlkB when present 
in vitro as well as in vivo. 
Chapter 5 describes Screening and evaluation of Indenones as potential 
inhibitors of human AlkBH3. The objective of this chapter was to screen and 
evaluate another library of indenone derivatives for inhibition of human AlkBH3. 
The library of 27 indenone derivatives was synthesized by Prof. Faiz Ahmed Khan’s 
research group, department of chemistry, IIT Hyderabad. In order to screen the 
library of 27 indenone derivtives for their inhibitory effect on the activity of human 
AlkBH3, direct repair assay was used. 40-mer oligonucleotide containing single 
3meC was used as substrate for the purified recombinant AlkBH3. After initial 
screening, three compounds (namely, 5c, 8f and 10a) were found to have some 
inhibitory effect on the human AlkBH3 activity. To determine the inhibitory 
potential of these three compounds IC-50 was calculated and the compound 5c was 
selected as the best hit and characterized further.  Next, the ability of the compound 
5c to form a complex with AlkBH3 was studied by using CD spectroscopy and ITC. 
Comparison of CD spectra of AlkBH3 and 5c-bound AlkBH3 indicated that there 
are subtle conformational changes induced by 5c binding which might involve only 
xx 
 
a few residues from a larger and structured domain, most probably the jelly roll fold 
where active site is located. Then, the binding affinity of 5c to AlkBH3 was 
determined by ITC. The data revealed tight binding between 5c and AlkBH3 with 
dissociation constant 7.8µM. Mechanism of inhibition of the compound 5c was 
determined by studying the steady-state enzyme kinetics. For this, the initial velocity 
of AlkBH3 was determined in the presence of increasing concentrations of 
compound 5c. The results indicated unchanged Vmax which is a characteristic 
feature of a competitive inhibitor. With respect to 2OG, the compound 5c showed a 
mixed type inhibitor. In order to get a better understanding of 5c-AlkBH3 
interaction, molecular docking studies were performed. Docking analysis 
demonstrated that 5c binding site lies in close proximity of the active site and it 
interacts with catalytically important residues of AlkBH3. Human AlkBH3 is 
overexpressed in non-small cell lung adenocarcinoma cell line A549 and 
AlkBH3 gene silencing inhibited A549 cell survival. In order to test the in vivo 
effect of 5c as AlkBH3 inhibitor, A549 cells were treated with increasing 
concentration of 5c and cell survival was monitored using MTT assay. It was found 
that 5c treatment indeed affected the viability and proliferation of A549 cells. 
Interestingly, MMS sensitivity of A549 cells was significantly increased in the 
presence of 5c, suggesting that compound 5c could be an inhibitor for AlkBH3. 
Thus, this chapter clearly established that the compound 5c could inhibit the 
function of AlkBH3 in vitro and in vivo and exhibited modest binding properties. 
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Chapter 1: Introduction 
 
1.1  Alkylation damage to DNA 
DNA is exposed to harmful alkylation damage by endogenous and exogenous agents 
at all times. Alkylating agents from the environment such as tobacco-specific 
nitrosamines and chemotherapeutic drugs used in cancer treatment such as 
Temozolomide, Melphalan causes alkylation damage in the DNA[1]. Alkylating 
agents can react with 16 different sites of the DNA bases [2]as well as with 
phosphate backbone of DNA generating methyl phosphoesters (MTE)[3] (Table 1).  
Alkylating agents can introduce methyl or ethyl groups at all of the available 
nitrogen and oxygen atoms in DNA bases, producing fifteen different types of base 
modifications [2]. Among these, N7-methylguanine (N7meG), 3-methyladenine 
(N3meA) and O6-methylguanine (O6meG), are specific to the double-stranded 
DNA [4]. Whilst N7-methylguanine is relatively harmless, N3meA has a strong 
toxic effect [4]. The methyl group of N3meA protrudes into the minor groove of the 
double helix, which is normally free of methyl groups (the methyl groups of thymine 
and 5 methylcytosines are in the major groove) [5]. N3meA efficiently blocks RNA 
polymerase and replicative DNA polymerases resulting in a strong cytotoxic but low 
mutagenic effect [6]. The low mutagenicity observed may be due to trans-lesion 
synthesis by DNA polymerases [7] . O6meG is highly mutagenic and directly 
demethylated by O6-methylguanine-DNA methyltransferase (MGMT) [8]. This 
protein transfers the methyl group to a Cystein residue within the active site 
resulting in self-inactivation [8]. In single-stranded DNA (ssDNA), N1-
methyladenine (N1meA) and N3- methylcytosine (N3meC) lesions are mostly 
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observed as all the other nitrogen lone pairs required for nucleophilic attack are 
occupied with hydrogen bonding in double-stranded DNA[9]. These lesions are 
cytotoxic but less mutagenic as they are unable to base pair but able to block DNA 
replication [1, 9, 10]. 
 
Table 1: Alkylation adducts caused by DNA damaging agents  
S. No. Alkylated base Fe(II)/2OG dioxygenase 
involved in repair 
Reference 
1. N1meA AlkB, AlkBH2, AlkBH3, 
AlkBH1 
[6, 11, 12] 
2. N3meA -  
3. N6meA AlkBH1, AlkBH5, FTO [13-15] 
4. N7meA -  
5. N3meT AlkB, AlkBH2, AlkBH3, 
FTO 
[6, 11, 12] 
[16, 17] 
6. N1meG AlkB, AlkBH1, AlkBH3 [6, 11, 12] 
[16] 
7. N2meG AlkB  [18] 
8. N3meG -  
9. N7meG -  
10. N1meC -  
11.. N3meC AlkB,  AlkBH1, AlkBH2, 
AlkBH3 
[6, 11, 12] 
12. N4meC AlkB  [18] 
13. O6meG -  
14. O2meT -  
15. O4meT -  
16. O2meC -  
17 Phosphate tri-ester -  
 
3 
 
1.2 DNA damaging agents 
Endogenous sources of alkylation damage come from many types of reactive 
byproducts generated from biochemical reactions inside cells. The enzyme cofactor 
S-adenosylmethionine (SAM) is the methyl donor in many biomethylation pathways 
and is produced in cells in high concentrations ranging from 20 μM to 50 μM [19, 
20] . This molecule can methylate DNA at a rate characteristic of weak alkylating 
agents [21, 22] . The peroxidation of lipids in the cell membranes by free radical 
byproducts of cellular metabolism can create alkylating agents that damage DNA. 
The main lesions produced by this mechanism are ethenoadenine (ϵA) and 
ethenocytosine (ϵC) [23]. The genomic DNA also gets methylated at N3 position of 
cytosine by non-specific demethylation activity of DNA methyltransferases 
(DNMTs) [24]. DNMT3a and 3b have been revealed as one of the major 
endogenous source of N3meC lesions as these enzymes introduce 3000-5000 
N3meC bases per genome [24] . Cells are also exposed to DNA damaging alkylating 
agents that occur in the environment and endogenously generated byproducts of 
cellular oxidative metabolism that leads to the damage in the genome. Some 
alkylating agents such as naphthyridinomycin and cyanocycline-A are used in 
cancer chemotherapy [25, 26] . Simple methylating agents, such methyl methane 
sulphonate (MMS), methylate DNA resulting N7meG and N3meA [27] . MMS also 
methylate single-stranded DNA and results in N1-meA and N3meC [10]. 
1.3 Cellular defense against alkylation damage 
To cope with the alkylation damage to DNA caused by endogenous as well as 
exogenous alkylating agents and to maintain the genome integrity, cells have 
evolved repair pathways against alkylation specific DNA damage. In E coli, 
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resistance to alkylation damage is orchestrated by an increased expression of four 
genes, namely, ada, alkB, alkA, and aidB, collectively called ‘ada regulon’ [28] .  
This coordinated response of cells to the alkylation damage is called the adaptive 
response or ‘ada response’ and their induction provides protection against alkylation 
damage to DNA[29]. The enzyme which has been known to be involved in repair of  
N1meA and N3meC is known as alkylation repair protein-B (AlkB) in E. coli [16]. 
AlkB is a Fe(II)-2-oxogluterate(2OG)-dependent dioxygenase which catalyzes the 
demethylation reaction. AlkB-catalyzed reaction is mechanism is initiated by the 
oxidative decarboxylation of 2OG to succinate and CO2 resulting in the removal of 
the methyl group from N1meA and N3meC [28, 30]. The methyl group is 
hydroxylated and spontaneously released as formaldehyde [31, 32]. AlkB deficient 
E. coli cells are prone to the accumulation alkylated lesions in the DNA. The AlkB 
deficient E. coli cells also show hypersensitivity towards alkylating agents [33]. 
E.coli AlkB is a 216 amino acids protein which has a characteristic double 
stranded beta helix (DSBH) protein fold that involves eight beta strands forming two 
four-stranded antiparallel β-sheets [34, 35]. AlkB structure consists of 3 well-
defined regions: (1) a catalytic core in the carboxy-terminal domain, (2) a nucleotide 
recognition lid and (3) N-terminal extension. As shown in Figure 1, AlkB has the 
characteristic H131..D133….H187 triad which is important for the coordination of 
Fe atom in the catalytic core [34] . In addition to the characteristic HDH triad, AlkB 
also has the RXXXXXXR motif where the first arginine residue is involved in the 
coordination of Fe atom while the other arginine is involved in AlkB-specific 
substrate binding[36]. The carboxylate moiety of 2OG forms salt bridge with R204 
and R210 residues of AlkB protein[36]. The N-terminal 1-90 amino acids of AlkB 
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constitute the nucleotide recognition lid. In the absence of DNA, this lid is flexible 
and allow access to the wide range of alkyl adducts containing substrate  [37]. In the 
open conformation of AlkB, the damaged base binds to a hydrophobic cavity where 
it is held by the base stacking interaction with H131 and W69 from the nucleotide 
recognition lid [37]. In the absence of bound substrate, Y76 flips away from active 
site thereby allowing the damaged base to access the catalytic core [37] . The T51-
Y55 loop shifts about 2.5Å from the active site upon binding of the substrate. In the 
closed conformation, the Y76 residue interacts with the damaged base and clamps it 
into the positions for the catalysis [37].  
1.4 Molecular mechanism of DNA dealkylation repair 
E. coli AlkB catalyzes oxidative demethylation reaction which requires Fe(II) and 
2OG as cofactor and co-substrate, respectively. Detailed mutational and structural 
studies have revealed molecular mechanism of AlkB catalyzed reaction. It promotes 
the two-electron oxidation of the substrate coupled with decarboxylation of 2OG to 
form succinate and CO2 leading to demethylation of the damaged base the 
restoration of undamaged base in the DNA. For Substrate binding, W69 and H131 
stack against the damaged base and facilitate substrate recognition by forming π-π  
interactions. W76 forms hydrogen bond interactions to the two phosphates 5′ of the 
methylated base which holds the substrate to the active site. AlkB modifies the DNA 
backbone around the alkylated base so that the alkylated base is flipped out into the 
active site and the two flanking bases are “squeezed” and stacked together. This base 
flipping mechanism is a characteristic feature of AlkB [38] . 
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Figure 1. Structure of AlkB and AlkBH3 showing active site residues. (A) The 
active site iron is co-ordinated by amino acid residues H131, D133 and H187. R210 
and R204 are involved in interaction with 2OG. (B) The active site of AlkBH3 is co-
ordinated by H191, D193 and H257. 2OG is co-ordinated by R131, R269 and R275. 
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Active site iron has a five-coordinate geometry: it is coordinated by H131, H187 and 
D133. The other two coordination sites are occupied by C1 carboxyl and C2 keto 
group of 2OG, respectively. C-5 carboxyl of 2OG hydrogen bonds to Y122 and 
N206 and thus held at the active site. This coordinated iron is utilized to activate the 
dioxygen molecule for oxidation of inert C-H bond [38] .  
1.5 Human homologs of AlkB 
The human Fe(II)-2OG-dependent dioxygenase family consists of over 60 members 
sharing conserved structural feature of AlkB, such as DSBH fold and HDH triad, 
necessary for iron and cofactor binding. All the members of this family also share 
the common mechanism of hydroxylation of their specific substrates [39, 40]. Apart 
from DNA dealkylation repair, Fe(II)-2OG-dependent dioxygenase are involved in 
range of metabolic processes viz (a) hydroxylation of Asp/Asn residues in epidermal 
growth factor-like domains, ankyrin repeat domains of the asparaginyl 
hydroxylase(ASPH) FIH, and splicing regulatory proteins (the lysyl-hydroxylase 
JMJD6), (b) antibiotic biosynthesis in prokaryotes (c) oxygen sensing in humans, (d) 
fatty acid metabolism and (e) chromatin modification and modification of proteins 
via demethylation of lysine residues [41]. Sequence analysis revealed that there are 
nine Fe(II)-2OG-dependent dioxygenase that are similar to E.coli AlkB and are 
known as AlkBH1-9 [42] [43]. 
AlkBH1 was the first discovered AlkB homologue in humans.  Protein 
sequence homology showed that AlkBH1 is structurally closest to AlkB among all 
the human homologues of AlkB [44]. The structural features also indicated that the 
protein is longer than AlkB by 71 amino acids in the N-terminus and 42 amino acids 
in the C-terminus[45]. The subcellular localization of AlkBH1 remains controversial 
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to date. Ougland et al showed that AlkBH1 is localized in the nucleus of human 
embryonic stem cells while Westby et al have reported AlkBH1 as a mitochondrial 
protein [46, 47]. Six different enzymatic activities of AlkBH1 have been reported in 
the literature. AlkBH1 has been reported to have weak N3meC demethylation 
activity in ssDNA and RNA. It does not repair other methylated bases such as 
N1meA double-stranded DNA [47]. AlkBH1 has been also reported to have a tRNA 
binding domain and demethylates N1meA at position 58 tRNA (N1meA58). It has 
been proposed that demethylation of N1meA58 by AlkBH1 signals degradation of 
tRNA, thus regulating the level of tRNA-iMet in the cells[14]. AlkBH1 also 
modifies the wobble base in the mitochondrial tRNA
met
 by oxidizing 5-methyl 
cytosine to generate 5-formylcytosine in the mitochondria [48]. These studies 
showed that apart from DNA repair, AlkBH1 also plays a direct role in 
mitochondrial translation regulation [49]. AlkBH1 has also been reported to 
demethylate Histone H2A [46]. Knockout studies have shown that ALKBH1
-/-
 mice 
die at an embryonic stage.  It has been reported that AlkBH1 regulates stemness by 
interacting with key transcription factors OCT4, NANOG and SOX2 which are 
essential for embryonic development[50]. Knockdown of ALKBH1 enhances the 
pluripotency markers and delay the induction of early differentiation genes. Mouse 
study from Pan et al have also emphasized the role of AlkBH1 in transcriptional 
regulation and showed that AlkBH1 knockout leads to trophoblast lineage 
defects[51]. Another study reported enzyme activity of AlkBH1 in demethylation of 
N6meA of DNA in the mouse embryonic stem cells. AlkBH1 deficient cells 
accumulate N6meA which leads to silencing of X-chromosome genes and delayed 
differentiation[52, 53]. Osteogenic differentiation in human mesenchymal stem cells 
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is regulated by AlkBH1 mediated demethylation of N6meA. Depletion of AlkBH1 
leads to accumulation of N6meA resulting in transcriptional silencing[52]. AlkBH1 
has also been reported to have DNA Apurinic/apyrimidinic lyase (AP lyase) 
activity[54]. The Ap-lyase activity is conserved across species[55]. The AP-lyase 
activity is independent of the Fe
II
/2OG and the catalytic site differs from the HDH 
triad [54, 56, 57]. AlkBH1 AP-lyase activity is mediated via β-elimination reaction. 
However, AlkBH1 does not play any role in the BER pathway [58]. It has been 
reported that K133 is a catalytically important residue with respect to AP lyase 
activity; K154 and K182 are located within 5Å of serine residues S136, S147, and 
S181 which could be essential residues for AP-lyase activity[45]. Crystallographic 
studies are required to determine precisely the AP lyase activity site in AlkBH1.  
Two human homologues, AlkBH2 and AlkBH3 were identified to have 
biochemical activity similar to AlkB[59, 60]. Human AlkBH2 repairs methylation 
damage preferentially in double-stranded DNA. It has very low activity on the 
ssDNA or RNA[61]. It has been reported to be mostly a housekeeping gene 
maintaining the genome integrity by repairing the methylation adducts N1meA and 
N3meC[35, 61] [16]. AlkBH2 has been found to have a rather promiscuous substrate 
specificity. It can demethylate a number of methyl adducts such as N1meA, N3meC 
and a number of etheno adducts in the genomic DNA by the base flipping 
mechanism[62]. It has been reported that AlkBH2 colocalizes in the nucleus where 
it interacts with PCNA in the replication fork during S-phase of the cell cycle[63, 
64]. AlkBH2 interacts with PCNA using a specific interaction motif identified on 
PCNA as AlkBH2-PCNA-interaction motif [65, 66]. Studies on mouse models have 
shown that AlkBH2
-/-
 mice are more sensitive to MMS induced cytotoxicity. 
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Mutation frequency also increases significantly in AlkBH2
-/-
  [67]. However, 
knockout studies have also shown that knockout of AlkBH2 or AlkBH3 neither 
affect the viability nor lead to any significant phenotype[68]. Mice study has shown 
that AlkBH2 knockout results in accumulation of methyl adducts in the genome, 
substantiating that AlkBH2 is essential for genome maintenance[69]. 
Overexpression of AlkBH2 has been reported in glioblastoma which made the cells 
resistant to chemotherapeutic agent temozolomide[70]. There have been reports of 
mutated forms of AlkBH2 expressing in certain brain tumor samples, colon cancer, 
and bladder cancer [71-74]. Rosic et al have found that DNMT3a and DNMT3b and 
have co-evolved with AlkBH2 among the eukaryotes. AlkBH2 is involved in repair 
of N3meC adducts generated non-specifically by DNMT3a and 3b. Loss of AlkBH2 
leads to accumulation of N3meC in the genome [24]. 
AlkBH3 is another human homologue of AlkB which has biochemical (DNA 
demethylation) activity similar to AlkB. AlkBH3 repair methylation damage 
primarily N1meA and N3meC from ssDNA and RNA as efficiently as AlkB. There 
are subtle differences in the substrate preference of AlkB, AlkBH2, and AlkBH3 
arising from the different amino acid residues present in their substrate binding 
pocket[16, 60]. AlkBH3 have been found to the only human AlkB homologue which 
can reactivate the phage mRNA by demethylation of the methylated residues[75]. 
AlkBH3 has been found to be co-localizing in the cytoplasm as well as the nucleus 
and does not exhibit any cell cycle-dependent variation in sub-cellular localization 
[59, 64]. AlkBH3 interacts with 3’-5’ helicase ASCC3 [76]. AlkBH3 has been also 
reported to repair N6meA in tRNA. It was found that tRNA modified by AlkBH3 
help in increasing translation efficiency [77]. Mouse knockout study showed that 
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absence of AlkBH3 did not result in any significant phenotype, but it was found that 
the triple knockout of AlkBH2, AlkBH3, and DNA glycosylase AAG caused a 
synergistic phenotype in inflammation-associated colon cancer suggesting the 
possibility of overlapping substrate specificity [71]. AlkBH3 overexpression has 
been associated with poor prognosis in a wide array of cancers. The relevance of 
AlKBH3 with cancer cell proliferation has been discussed in detail in section 1.6. 
AlkBH4 has been recently identified as Fe(II)-2OG dependent dioxygenase 
based on structural conservation but the substrate specificity and biological 
functions remain largely unknown[78]. Protein-protein interaction study has shown 
that AlkBH4 interacts with proteins involved in chromatin regulation and 
transcription[79]. ALKBH4
-/- 
 mice were found to be embryonic lethal[80]. AlkBH4 
has been found to be involved in demethylation of K84 in actin and play some role 
in actin-myosin regulation dynamics.  AlkBH4 co-localizes with the actomyosin-
based contractile ring and mid-body via association with methylated actin[15]. 
AlkBH4 knockout studies also revealed that it is essential for the completion of 
meiosis. AlkBH4 knockout leads to leads to the insufficient establishment of the 
synaptonemal complex [15, 80]. The detailed study of the enzymatic function of 
AlkBH4 in vitro and in vivo is not yet reported. 
AlkBH5 is a hydroxylase which catalyzes demethylation of N6meA methyl 
group from RNA[81]. AlkBH5 is co-localized in the nucleus. ALKBH5
-/-
 mice 
display impaired male fertility resulting from compromised spermatogenesis, 
aberrant apoptosis, and altered gene expression in the testes[81, 82]. Human 
AlkBH5 has been reported to be induced under hypoxia and has been suggested to 
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have a direct interaction with Hypoxia-Inducible factor ( HIF) in MCF-7, U2OS and 
IMR-32 cells[83]. 
AlkBH6 has been found to be localized in the nucleus as well cytoplasm in 
normal human tissues [84] . The in vitro enzyme activity, substrate specificity and in 
vivo significance of AlkBH6 has not been characterized to date. 
AlkBH7 has been reported as a mitochondrial protein with a conserved 
mitochondrial localization signal. AlkBH7 has been associated with programmed 
necrosis [85, 86] . Programmed necrosis refers to the programmed cell death which 
is mediated by receptor-interacting protein kinase-1 and 3; and is independent of 
caspase mediated cell death signaling pathway [87]. It has been observed that 
AlkBH7 knockout makes the cells resistant to cell death which is induced by 
alkylating agents namely, MMS [85] . Knockout of AlkBH7 in mouse models leads 
to obesity indicating that AlkBH7 plays a role in fatty acid metabolism [88]. The 
substrate specificity and in vitro activity of AlkBH7 is yet to be characterized. 
AlkBH8 has been characterized as Fe(II)/2OG dependent dioxygenases with 
tRNA methyltransferase domain [89]. Along with the conserved HDH triad, 
AlkBH8 also possesses an RNA recognition motif (RRM) and methyltransferase 
domain. methyltransferase domain of AlkBH8 catalyzes the methylation of 5-
carboxymethyluridine to 5-methoxycarbonylmethyluridine in tRNAs with UPyN 
(Py = C/U) as an anticodon triplet sequence, whereas the AlkB domain catalyzes the 
hydroxylation of 5-methoxycarbonyl methyluridine to S-5-(methoxycarbonyl 
hydroxymethyl)uridine specifically in tRNAGly (UCC)[90-93]. 
AlkBH9 is also known as fat and obesity associated protein (FTO). 
AlkBH9/FTO has been characterized to have RNA demethylation activity. It has 
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been known to hydroxylate N3meT and N3meU in the mRNA [17, 94]. Recent 
reports have shown that N6meA is the major substrate for FTO[95]. Mouse model 
studies have shown that FTO knockout leads to reduced adipose tissues and 
enhanced metabolism[96]. Genome-wide association studies have shown that there 
is a strong link between FTO polymorphism and type II diabetes and obesity [96-
100]. Extensive efforts are being made to identify small molecule inhibitors for 
FTO. In summary, it can be said that most of the human AlkB homologues are 
multi-functional and there are many more functions likely to be discovered for these 
proteins besides the nucleic acid repair or regulation of epigenetic methylations 
activity reported so far.  
1.6 AlkBH3 and Cancer 
Of the nine AlkB homologs AlkBH2 and AlkBH3 have been well established to 
have DNA repair activity similar to AlkB.  AlkBH3 has been primarily associated 
with repair of methylation damage in single-stranded DNA and RNA [16] . AlkBH3 
has been known to be up-regulated in several cancers [101] . AlkBH3 is highly 
expressed and associated with poor prognosis in several types of cancers. It has been 
shown that AlkBH3 binds to the promoter of genes important for transcriptional 
regulation[102]. It has been proposed to be essential for maintaining the genomic 
integrity of cancer cells.[102] 
AlkBH3 is initially identified as one of the Prostate cancer antigen as it is 
overexpressed in androgen-independent prostate cancer cells and cancer survival is 
dependent on AlkBH3 expression [103, 104] . RNAi mediated knockdown of 
AlkBH3 in prostate cancer cell lines PC-3 has resulted in the induction of apoptosis 
[104]. It is overexpressed in Castratation-resistant and hormone-independent 
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prostate cancer [105].  AlkBH3 knockdown also inhibited anchorage-independent 
cell growth of prostate cancer cell line DU145 [105] . The in vivo gene silencing 
also lead to reduced tumorigenesis via decreased Akt activity and hence reduced 
PI3K-Akt pathway [105] . Effort to design an AlkBH3 inhibitor has led to the 
discovery of HUHS015, as a small molecule inhibitor for AlkBH3 [106]. 
AlkBH3 is also overexpressed in pancreatic cancer and promotes cancer cell 
proliferation [107] . Like prostate cancer, high level of AlkBH3 in pancreatic cancer 
is associated with poor prognosis. RNAi mediated silencing of AlkBH3 in PANC-1 
cells reduces VEGF expression and leads to suppression of cell proliferation [107] . 
AlkBH3 plays an important role in the progression of human urothelial carcinoma. 
AlkBH3 is overexpressed in KU7 urothelial carcinoma cell line. RNAi mediated 
knockdown of AlkBH3 in KU7 cells leads to cell cycle arrest in G1 phase. In these 
cells, AlkBH3 acts as an upstream molecule to NOX-2-ROS and Tweak/VGEF 
signaling thus promoting tumor survival and angiogenesis [108]. 
AlkBH3 was found to be contributing significantly to cancer cell survival 
and proliferation of lung adenocarcinoma [109] . It has also been proposed as the 
therapeutic target for lung adenocarcinoma and squamous cell carcinoma [109] . 
Mouse model studies have shown that RNAi mediated silencing of AlkBH3 in non-
small cell lung cancer cells A549 leads to reduced proliferation. Knockdown of 
AlkBH3 inhibits cancer proliferation by inducing cell cycle arrest at G2/M phase 
leading to senescence or induction of apoptosis[109].  The phenotype induced by 
AlkBH3 knockout in lung cancer cell lines depends on the TP53 status of cells. In 
the cell lines with wild-type TP53 (e.g., A549 or NCI-H1650), AlkBH3 knockdown 
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leads to cell cycle arrest; while AlkBH3 silencing leads to apoptosis in cell lines 
expressing mutated p53 [110]. 
AlkBH3 has also been associated with renal cell carcinoma (RCC) which is 
the most common type of kidney cancer [111] . High level of AlkBH3 in RCC cell 
line CAKI-1 are related to tumor metastasis and progression. Knockdown of 
AlkBH3 by siRNA resulted in the induction of apoptosis and reduced cancer cell 
proliferation.  The high AlkBH3 expression is also linked to poor prognosis [111].  
AlkBH3 was found to be inactivated in breast cancer patients [112] . The promoter 
region of AlkBH3 was found to undergo aberrant methylation in the CpG Island 
resulting in gene silencing. Higher levels of promoter methylation were associated 
with reduced patient survival [112]. Both AlkBH2 and AlkBH3 were found to be 
mutated in glioma patients. AlkBH2 I141V mutation and AlkBH3 D189N mutations 
were found in patient samples. These mutant proteins were overexpressed in brain 
tumor samples. Overexpression might be responsible for repairing the DNA damage 
caused by therapeutic alkylating agents during chemotherapy thereby reducing the 
efficiency of therapy.[72] AlkBH3 was also found to be overexpressed and involved 
in carcinogenesis in colorectal cancer. The significance of AlkBH3 overexpression 
in the prognosis of cancer has not been elaborately studied yet[113]. Candidate gene 
study has found AlKBH3 as one of the genes associated with papillary thyroid 
cancer[114]. AlkBH3 has also been associated with hepatocellular carcinoma. High 
expression of AlkBH3 was found in patient samples with poor prognosis[115]. 
Alkylating agents are extensively used as chemotherapeutic agents, which 
damage the DNA and cause replication fork stalling ultimately leading to loss of 
genome integrity and cell death. AlkbH3 assists in cell survival and cancer 
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proliferation. Being a DNA repair protein, it associated with replication fork and 
repairs the methylation damage caused by chemotherapeutic agents. Since the 
cancer cell proliferation is dependent on AlkBH3 overexpression, AlkBH3 can be a 
potential anti-cancer therapeutic target.  
1.7 Inhibition of AlkBH3 
As described in the previous section, AlkBH3 has been extensively studied as a 
regulatory gene involved in promoting tumor cell proliferation and metastasis of 
cancer. Extensive efforts have been directed towards developing selective inhibitors 
for AlkBH3 (Table 2). AlkBH3 inhibitors can be potentially used in combination 
therapy with alkylating agents; which can be significantly effective in reducing the 
amount of alkylating agents used in cancer chemotherapy. There have been multiple 
approaches towards designing inhibitors of AlkBH3. One stream of studies has been 
entirely focused on the biochemical mechanism of action of molecule, its chemical 
characterization, and its binding parameters. However, the in vivo significance of 
inhibition remains lagging and there is no data relating to the in vivo activity of the 
molecule.  Cell permeability, toxicity and other in vivo parameters of the molecule 
remain unaccounted. Another approach for inhibitor design has been focused on the 
pre-clinical inhibition studies of AlkBH3. Extensive studies have been carried out 
using cell lines and mouse models to study the in vivo effect of the lead molecule, 
however, the biochemical parameters for enzyme-ligand binding have not been 
studied. Although the molecule shows in vivo tumor growth inhibition, the 
mechanism of action, affinity of the molecule, binding pocket, and other 
biochemical parameters remain unknown, hence limiting the possibility of 
improvement and design of other analogs with more efficiency. It appears that a 
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combined approach towards designing of AlkBH3 inhibitors is lacking. A combined 
study should include studying the biochemical parameters such as the mechanism of 
action, binding affinity, binding pocket in the protein cavity as well as in vivo study 
as the guiding principle for design of the small molecules. The inhibitor should be 
then studied using cell lines and mouse models to understand the pharmacokinetics 
and pharmacodynamics.  
One major concern while designing inhibitors for this class of enzymes is the 
selectivity of small molecule inhibitors. Due to the similar catalytic mechanism 
followed by this large family of enzymes, targeting one of the enzymes selectively is 
a difficult task.  There have been very few studies with a combined approach where 
AlkBH3 has been targeted selectively. In order to achieve specificity, the emphasis 
should be on targeting the substrate binding pocket as the site for inhibitor binding. 
The substrate binding pocket for each member of the AlkB family has been 
attributed to unique properties so that different proteins bind to a wide range of 
substrates. Those amino acid residues should be targeted to selectively inhibit these 
enzymes[116]. 
 The crystal structure of AlkBH3 shows that the iron is coordinated by H191, D193 
and H257 (Figure 1B). The substrate binding pocket of AlkBH3 is more polar 
compared to AlkB and AlkBH2. There is a hairpin loop extended by three amino 
acid residues R122, E123 and D124 which makes the DNA binding groove 
comparatively more negatively charged (Figure 2). This unique feature of AlkBH3 
is also defined as RED fist [117, 118]. These unique characteristics of the enzyme 
could be targeted so as to achieve selective inhibition.  However, one of the factors 
hindering the design of AlkBH3 inhibitor is the fact that the crystal structure of 
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AlkBH3 lacks the N-terminal 69 residues. Multiple Sequence alignment of AlkBH3 
sequence across species shows that the N-terminal region of AlkBH3 is highly 
conserved. The well-defined nucleotide recognition lid in AlkB is formed by the 
first 90 amino acid residues. No such feature has been defined in the truncated 
AlkBH3 structure. AlkBH3 N-terminal 69 amino acids could be functionally 
important. Secondly, there is no AlkBH3 structure with a bound DNA substrate 
available, unlike AlkB and AlkBH2. Availability of substrate-bound structure 
reveals crucial information about the interacting residues, their three-dimensional 
geometry, and overall protein folding and provide an insight into designing 
inhibitors.  
Several generic Fe(II)-2OG-dependent dioxygenase inhibitors have been identified 
that compete 2OG biding [119]. These compounds act as nonreactive analogs of 
2OG, and their functionalization enables inhibition, either by increasing potency 
towards a particular 2OG oxygenase or by blocking binding to another oxygenase.  
Most of the molecules targeting the active site have been found to be the generic 
inhibitors for FeII-2OG dependent dioxygenase family. Welford et al have 
extensively studied the inhibition of this family of enzymes using 2OG analogs. 
They have found N-oxalyl glycine (NOG), N-oxalyl-4s-alanine, N-oxalyl-4r-
alanine, 2-thiono derivative of NOG, 2-hydroxygluterate and 2-mercaptogluterate be 
a generic inhibitors for AlkB family [119] . These compounds are essentially 
analogs of 2OG. Crystallographic studies have shown that these molecules bind to 
the active site of AlkB. Several structural analogs of NOG have also been screened 
for potent AlkB inhibitors. N-oxalyl-L-cysteine derivatives 1 and 3-hydroxypyridine 
carboxamides have been identified as potent inhibitors of AlkB family [120] . There 
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have not been any studies relating to the in vivo efficiency of 2OG analogs as 
inhibitors of AlkB family. Inhibition of AlkB and its human homologues using DNA 
aptamers were also studied. Highly efficient aptamer for AlkB was characterized 
which binds to AlkB with nanomolar affinity [121, 122] . Inhibition of AlkBH2 
using aptamer was also studied [121, 122] . The aptamers are highly potent in 
targeting this sub-family of enzymes as they bind selectively in a non-competitive 
manner to both DNA substrate and co-substrate 2OG[121, 122]. However, no such 
aptamer has been identified for AlkBH3 inhibition which is clinically more crucial 
drug target than AlkBH2. Also, the in vivo significance of aptamer-based drug 
candidate needs to be established.  The in vivo evaluation of aptamer-based 
inhibitors for AlkB has not been done. 
Glutamine deficiency also leads to inhibition of AlkBH family of enzymes 
by depleting the levels of 2OG in tumors which are Myc and K-Ras driven [123] . 
The levels of 2OG are maintained by TCA cycle in these cells. 2OG is an essential 
co-substrate for AlkBH enzymes, depletion of which leads to the inactive enzyme. 
This implies that small molecule inhibitors of glutamine metabolism such as DON 
(6-Diazo-5-oxo-L-norleucine), CB-839, and BPTES (Bis-2-(5-phenylacetamide-
1,3,4-thiadiazol-2-yr)ethyl sulfide) would be potential inhibitors of AlkB family of 
enzymes [123]. 
 
 
 
20 
 
 
 
 
 
 
 
 
Figure 2: Hydrophobicity analysis of AlkBH3 structure (2IUW) and AlkB structure 
(3I2O) shows that the DNA binding pocket of AlkBH3 is comparatively rich in 
polar amino acids compared to AlkB. 
AlkBH3 
AlkB 
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Copper ion has also been identified as an inhibitor of AlkB and its human 
homologues AlkBH2 and AlkBH3 under Wilson’s disease conditions  [124] . The 
normal cellular concentration of copper does not affect the activity of these 
enzymes, but under Wilson’s disease condition the cellular concentration of copper 
goes up and accumulation of Cu(II) ions inhibit AlkBH2 and AlkBH3 activity [124]. 
Oncometabolites are another important group of AlkBH3 inhibitors. 
Molecule 2-hydroxyglutarate (2HG) and its two stereoisomers (D- and L-2HG) have 
been characterized as inhibitors of AlkB family of enzymes AlkBH2 and AlkBH3 
[125, 126] . These molecules are generated in tumor cells due to a mutation in TCA 
cycle enzyme iso-citrate dehydrogenase 1 and 2 (IDH1 and IDH2). Tumor-derived 
mutant forms of IDH catalyze the NAD-dependent dehydrogenation of 2OG to D-2-
hydroxyglutarate (D-2HG), in renal cell carcinomas and in tissues under hypoxic 
conditions. These compounds act as competitive inhibitors of 2OG [125, 126]. 
A flavonoid Quercetin, which is an iron chelator, has also been studied as an 
inhibitor of FeII/2OG dependent dioxygenases. It has been found that Quercetin 
depletes the cellular iron levels below 1µM thereby inhibiting enzymes such as 
PHDs and AlkB by non-specific iron chelation [127, 128]. 
Tanaka and co-workers have screened a library of pyrazole derivatives for 
AlkBH3 inhibition and found HUHS015 to be a potent AlkBH3 inhibitor [106, 129, 
130]. The study has been focused on the pre-clinical aspect of AlkBH3 inhibition in 
prostate cancer cell lines and xenograft mouse model without molecular 
characterization. The important aspects of drug targeting such as bioavailability, 
toxicity, dosage have been characterized. However, the key biochemical mechanism 
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remains to be determined. Also, subfamily selectivity, which is a major concern 
while designing inhibitors for AlkBH family has not been studied. Ueda et al 
screened another chemical library and identified compound 7l as an inhibitor of 
AlkBH3 which was more potent than HUHS015 [129]. The study has shown the 
characterization of the compound in vivo and extended their pre-clinical data on 
mice with prostate cancer. They have tested the AlkBH3 inhibition by compound 7l 
in vitro as well as in vivo conditions. However, the in vitro characterization of the 
compound such as the mechanism of inhibition, binding affinity, selectivity and 
determination of the binding pocket has not been done [129]. 
Another AlkBH3 inhibitors studied recently is rhein [131]. Li et al have 
studied the biochemical mechanism of inhibition by rhein followed by in vivo effect. 
But, this study has not been extended to the pre-clinical level. Another limiting 
factor to Rhein is that it does not target AlkBH3 selectively. Rhein has been shown 
to inhibit activities of bacterial AlkB and Human another AlkB human Homologue 
FTO[132]. Since Rhein is not a selective inhibitor, it cannot be a potential lead 
molecule to target cancer cells dependent on AlkBH3 expression. 
Recently, Das et al have developed a new technique involving zwitterionic 
peptide-based tags to differentiate between proteins of a subfamily [133]. Using the 
technique they have identified selective inhibitors to AlkBH3, AlkBH5, and FTO  
[133]. They have shown compound 8 to be a selective inhibitor of AlkBH3. They 
have also proposed the binding site of ligand to be the DNA binding pocket of 
AlkBH3. Compound 8 has been proposed to be interacting with residues essential 
for DNA binding [133], however, crystallography studies need to be performed to 
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substantiate the results. Also, the in vivo effect of compound 8 remains unknown, 
which is required for characterization of this compound as a lead molecule [133]. 
  
Table 2: Inhibitors of AlkB and AlkBH3 reported in the literature 
 
Inhibitor Name Target Reference 
Analogs of 2OG 
(N-oxalyl-4s-alanine,  
N-oxalyl-4r-alanine,  
2-thiono derivative of NOG,  
2-hydroxygluterate and 2-
mercaptogluterate) 
AlkB Welford et al,  [119] 
Analogs of 2OG 
(N-oxalyl-L-cysteine derivatives- 
1and3-hydroxypyridine arboxamides) 
AlkB Woon et al,   [120] 
Glutamine metabolism inhibitors 
(Glutaminase inhibitors- DON,  
CB-839, BPTES) 
AlkBH3 Tran et al,  [123] 
DNA aptamers 
(5’ TGC CTA GCG TTT CAT TGT CCC 
TTC TTA TTA GGT GAT AAT A 3’) 
AlkB, 
AlkBH2 
Krylova et al,  [122] 
Copper ion 
(Cu
2+ 
) 
AlkB 
AlkBH2 
AlkBH3 
Bian et al,  [124] 
Oncometabolite 
(D- and L-2Hydroxygluterate) 
AlkB 
AlkBH2 
AlkBH3 
Chen et al,  [125] 
Iron chelator 
(Quercetine) 
AlkB Triantafyllou et al,  [127] 
Pyrazol derivative HUHS015 AlkBH3 Ueda et al,  [77] 
Rhein AlkB, 
AlkBH2 
AlkBH3 
Li et al,  [131] 
Sulphonamide analog 
(compound 8) 
AlkBH3 Das et al,  [133] 
 
1.8 Indenone derivatives as AlkBH3 inhibitor 
Indenone is a biologically important structural motif present in several natural 
products. [134]. Indenone derivatives have garnered a wide attention in medicinal 
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chemistry as indenone analogs have been used for a variety of applications. For 
example, euplectin is a lichen derived indenone derivative which has cytotoxic 
properties against murine P-815 mastocytoma cell line[135]. The indenone core is 
also found in resveratrol-derived natural products such as plauciflorol-F which are 
known to inhibit cancer proliferation[136]. The indenone core is also present in the 
neo-lignin isolated from the fruit of Virola sebifera and 3-arylindenone has been 
found to have anti-tumor activity[137]. From the synthetic chemistry point of view, 
indenone is a neutral molecule which is well suited to derivatization. Several 
indenone analogs have been synthesized and their biological activity has been 
evaluated. Indenone derivatives have been studied as agonist for PARP activation in 
type II diabetes [138]. Indenone analogs were found to be moderate inhibitors of 
estrogen receptors. Structural analogs of indenone have also been used as a 
fluorescent binding agent to estrogen receptors[139, 140]. Several 2-arylidene-1-
ones have been screened for inhibition of estrogen receptor-β and estrogen receptor-
α[141]. Indenone analogs have been used as a novel scaffold for targeting Androgen 
receptors in breast cancer[142]. Indenone derivatives have shown tubulin inhibition 
without any cytotoxicity in breast cancer cell line MCF-7[143]. Indenone analogs 
have also been explored as anti-mitotic molecules for targeting tubulin. The 
molecule can be used as an anti-cancer drug[144]. Derivatives with indenone core 
have also been evaluated for inhibition of tyrosine kinase activity of Fibroblast 
Growth factor Receptor (FGFR) and loss of FGFR regulation has been associated 
with several vascular diseases[145]. Indenone derivatives have been studied as 
inhibitors of cyclooxygenase-2 (COX-2) as well. Structural analogs of nimesulide 
and flosulid having indenone skeleton were studied as selective inhibitors of COX-
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2[146]. Indenone derivatives have also been used as fermentation activators, 
estrogen binding receptors, and precursors for gibberellins[147].  
In the present study, one indenone derivatives were evaluated as the inhibitor 
for Fe(II)-2OG-dependent dioxygenase and one compound 5c was identified as a 
selective inhibitor for human AlkBH3 and another compound 3o was identified as a 
selective inhibitor for AlkB. The biochemical parameters for these small molecules 
interacting with AlkBH3 and AlkB have also been characterized.  
 
 
Figure 3: Summary of AlkBH3 inhibitors 
 
1.9 Significance and specific objectives 
AlkB and its human homologs AlkBH2 and AlkBH3 are essential for maintaining 
the genome integrity by removing methyl adducts from DNA which are potentially 
mutagenic. A thorough understanding of the substrate preference and mechanism of 
DNA repair is essential for determining the suitable strategy to inhibit these 
enzymes. AlkB and its human homolog AlkBH3 have been known to prefer N3meC 
and N1meA adducts on single stranded DNA as substrate; however, it is also well 
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established that single stranded regions of the DNA remain coated with ssDNA 
binding protein SSB. Thus, it is important to understand how presence of SSB 
affects the activity of AlkB. Since the studies for selective inhibition of AlkB family 
of enzymes have not been able to achieve the sub-family selectivity, it is essential to 
study the designing and mechanism of small molecule inhibitor for AlkB, which 
could then provide a scaffold and act as guiding principle for designing small 
molecule inhibitors for AlkBH1-8. The role of AlkBH3 in promotion of cell 
proliferation and metastasis of cancer has been widely studied. Since AlkBH3 
overexpression has direct implication on cancer cell survival, selective inhibition of 
these enzymes will prove to be an effective as combinatorial therapy along with 
chemotherapeutic agents. It could be speculated that inhibition of AlkBH3 repair 
pathway will lead to accumulation of DNA damage. DNA damage can be tolerated 
by cell to certain extent beyond which it will lead to stalling of replication fork 
causing cell to undergo apoptosis. Genome instability is one of the major driving-
force of cancer. The activity of repair pathways is coordinated by damage signaling 
network which is lost in case of cancerous cells thus, uncontrolled DNA repair 
promotes genome instability and cancer progression [148]. DNA repair inhibitors 
can be implemented for reducing the amount of cytotoxic alkylating agents used in 
cancer chemotherapy such as mechlorethamine, chlorambucil, cyclophosphamide, 
busulfan, dacarbazine (DTIC) [149-151].  Also, cancer cells usually have high 
metabolic rate, which leads to generation of endogenous alkylating agents such as 
SAM. These damages are repaired by direct repair pathway. Inhibition of AlkBH3 
may cause extensive DNA damage in cells endogenously, ultimately causing 
prolonged cell cycle arrest.  [152]. The synthesis of inhibitors of AlkB family is 
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important for targeting cancer cells which are heavily dependent on AlkBH3 for 
genome maintenance. Cancer cells often have several DNA repair pathways 
inactivated and they rely on a few DNA repair enzymes. Targeting these enzymes 
may lead to loss of genomic integrity and cell death due to synthetic lethality. 
AlkBH3 inhibitors in combination with other chemotherapeutic drugs may also be 
synthetic lethal in cancers such as lung adenocarcinoma, prostate and pancreatic 
cancer which are dependent on the AlkBH3 overexpression. 
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1.9.1 Specific objectives 
 Functional characterization of E. coli DNA dealkylation repair protein AlkB 
 Interaction of AlkB with SSB 
 Screening and evaluation of indenone derivatives as AlkB inhibitors 
 Screening and evaluation of Indenone derivatives as human AlkBH3 
inhibitors. 
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Chapter 2: Functional characterization of E. coli DNA repair 
protein AlkB 
 
2.1 Introduction 
DNA is constantly damaged by many endogenous and exogenous alkylating agents 
and alkylated DNA adducts are formed [1]. N1meA and N3meC are two 
methylation adducts which are specifically generated by SN2 type methylating agent 
MMS and prevent proper Watson-Crick base-pairing. E. coli DNA repair enzyme 
AlkB, a Fe(II)-2OG-dependent dioxygenases, is involved in the repair of N1meA 
and N3meC  [2]. AlkB repairs the damaged DNA by catalyzing hydroxylation of 
methyl group present on the ring nitrogen atoms and subsequently the oxidized 
methyl group is released as formaldehyde, thus restoring the undamaged nucleotides 
in the DNA [3]. AlkB has been known to preferentially repair methyl adducts found 
in ssDNA [4]. However, it is well known that bacterial ssDNA regions are stabilized 
by protein binding, such as, single-stranded DNA-binding protein SSB. E. coli SSB 
is a tetrameric protein and each monomer has three domains: the characteristic 
oligonucleotide/oligosaccharide binding (OB) domain [5] that binds ssDNA and C-
terminal domain acidic domain (CTD) [6], characterized as binding domain for 
several proteins involved in DNA metabolism [7] and an intrinsically disordered 
linker (IDL) domain. For the E. coli SSB, two major DNA-binding states were 
reported [9], (SSB)65, where the tetramer binds to 65 nucleotides at high salt 
concentration (NaCl concentration >200 mM), and (SSB)35, where the SSB binds to 
35 nucleotides at lower salt concentration (NaCl concentration <20 mM). Single 
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molecule experiments have demonstrated that SSB binding to ssDNA is not static, 
rather, it diffuses randomly back and forth along ssDNA [9] and the DNA ends 
undergo spontaneous unwrapping. SSB plays direct role in the DNA replication and 
recombination [10]. During recombination, SSB helps in heteroduplex formation by 
binding to the displaced strand and preventing strand annealing [11]. SSB is also 
involved in DNA repair pathways including base excision repair and recombination 
repair [12-14]. 
 
 
 
 
 
Figure 4. Structure and binding modes of E. coli SSB (A) Structural model of 65 
nucleotides of ssDNA (red ribbon), wrapped around the EcSSB tetramer in the 
(SSB)65 mode. (B) The proposed ssDNA binding pathways of the (SSB)65 and 
(SSB)35 modes of SSB (C) Domain organization of SSB, depicting the DNA 
binding domain (OB), IDL and the C-terminal acidic domain (CTD). 
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2.2  Materials and methods 
2.2.1 Cloning 
AlkB gene was cloned into pTYB3 vector using NcoI and XhoI restriction enzyme 
sites. Oligonucleotides used for cloning were shown in Table 3. SSB was also 
cloned into pTYB3 vector using NcoI and XhoI site. SSB-1-115 was cloned using 
internal deletion method from pTYB3-SSB clone. 
Table 3: Cloning strategy for generation of clones described in 2.2.1. 
Clone Clone 
No. 
Oligo 
Sequence (5’ – 3’) 
Restriction 
sites 
pTYB3
-SSB 
251 pTYB3_SSB_SalI_F 
AAT AGT CGA CAT GGC CAG CAG AGG 
CGT AAA CAA GG 
pTYB3_SSB_EcoRI_R 
TTA TGA ATT CGA ACG GAA TGT CAT 
CAT CAA AGT CC 
EcoRI 
Xho1 
pTYB3
-SSB-
del 
CTD 
252 Tagless SSB delta CTD_F 
GAA TTC CTC GAA GGC TCT TCC TGC 
TTT GCC 
Tagless SSB delta CTD_R 
ACC ACC CAG CAT CTG CAT GGT GCC 
GCC AAC 
Internal 
deletion 
pTYB3
-AlkB 
253 pTYB3_AlkB_NcoI_F 
ATT ACC ATG GAA ATG TTG GAT CTG 
TTT GCC GAT GCT G 
pTYB3_AlkB_Sal1_R 
TTT TGT CGA CTT CTT TTT TAC CTG CCT 
GAC GG 
Nco1 
Xho1 
 
2.2.2 Purification of recombinant proteins 
AlkB, SSB and SSB-1-115 were expressed as chitin-fusion protein and purification 
was carried out using chitin agarose, as suggested by NEB protocol. pTYB3-AlkB, 
pTYB3-SSB and pTYB3-SSB-1-115 plasmids were transformed into the E. coli 
strain BL21- CodonPlus(DE3)-RIL (Stratagene). BL21+pTYB3-AlkB or 
BL21+pTYB3-SSB or BL-21+pTYB3-SSB-1-115 transformed colonies were 
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inoculated into 100ml LB-broth with 100 μg/ml ampicillin and grown on incubatory 
shaker at 37ºC at 200 rpm. The grown culture was 20 fold diluted into 2L fresh TB-
broth with 100 μg/ml ampicillin. Incubation was carried out at 37ºC at 200 rpm for 3 
hrs. The culture was then induced with 1mM IPTG and kept for 5 hrs at 30ºC at 200 
rpm. Cells were harvested after centrifugation at 8000 rpm for 15 minutes at 4ºC. 
The cell pellet was re-suspended in 20ml of 50mM Tris-HCl buffer (pH 8.5) 
containing 300mM sodium chloride, 0.1% Triton-X, 1mM Imidazole and sonicated 
for 30 minutes. The sample was then centrifuged at 14,000 rpm for 20 minutes at 
4ºC to remove insoluble debris. The soluble fraction was mixed with 2ml of chitin 
resin pre-equilibrated with the same buffer and allowed to rotate in rotary shaker for 
4h to allow the protein to bind to the resin. The sample was then centrifuged at 1000 
g for 5 minutes at 4ºC and the beads were washed six times with 150 ml wash buffer 
(50 mM Tris,pH8.5, 350 mM NaCl, 0.1% Triton-X and 5 mM Imidazole). After 
washing beads were centrifuged as at 1000g for 4 minutes at 4ºC. Bound protein 
was eluted with elution buffer (10 mM Tris, pH 6.5, 100 mM NaCl, 400 mM 
Imidazole). The beads were incubated with 6.5 pH buffer for 5 hours and the protein 
gets cleaved under low pH conditions. 
For tag-less protein production, Proteins were further purified by Superose-12 (GE 
Healthcare) gel filtration column and analyzed using an AKTA Prime FPLC system 
(GE Healthcare). The purity of the proteins was analyzed by 12% SDS-PAGE 
followed by Coomassie Brilliant Blue staining and concentrations were determined 
by Bradford assays (Bio-Rad). 
2.2.3 N3meC containing oligonucleotide substrate 
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70-mer oligo nucleotide substrate consisting of 69 thymine and single N3meC at 
35th position, 15th position or at 1st position was chemically synthesized (Active™-
Imperial Life sciences). Shorter oligonucleotides (10-mer) containing N3meC at 5th 
position were also synthesized. 
2.2.4 Preparation of Methylated DNA substrate 
M13mp18 ssDNA was purchased from NEB and MMS treated to generate methyl 
adducts and purified following our previously published protocol [15]. Methylation 
adducts were generated by treating the oligonucleotide with MMS (Sigma, 129925). 
40 μg ssDNA oligonucleotides was incubated with 5% (v/v) (0.59 M) MMS, 200 
mM K2HPO4 in 500μl of total reaction at room temperature overnight ( 14-15hrs ). 
Excess MMS was removed by dialysis against TE buffer (10 mM Tris-HCl, pH 8.0, 
1 mM EDTA) using Spectra/Por dialysis membrane (MWCO: 1000). Then the 
damaged substrate was precipitated by adding 0.3 M sodium acetate pH 5.2 and one 
volume of ice-cold Iso-propanol. The precipitated ssDNA was washed with 80% 
ethanol and finally dissolved in molecular grade water [15]. 
2.2.5 Preparation of Acetoacetanillide 
10x stock of Acetoacetanilide (Sigma-538329; Mol wt-177.2) was prepared by 
dissolving it in DMSO to a final concentration of 0.5mM [16]. 
2.2.6 Preparation of ammonium acetate 
A 5M solution of ammonium acetate (Sigma A-1542; Mol. Wt. 77.08) was prepared 
by dissolving it in water. This 5M solution was used as 2.5X stock [16]. 
2.2.7 10X demethylation assay buffer 
10X assay buffer was made using the composition: 200mM HEPES pH7.5, 2mM 2-
oxogluterate, 20mM L. ascorbate and 200µM Fe(NH4)2SO4. 200mM stock of L. 
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ascorbate prepared in water, 20mM stock of 2-oxogluterate prepared in water and 
1mM stock Fe(NH4)2SO4  prepared in water were used for buffer preparation. All 
the stocks were prepared fresh. All the components were added in the same order as 
mentioned above. The buffer was prepared in a 50ml tube which was kept on ice all 
the time. The prepared solution shows a tinge of pink colour when prepared 
correctly. The buffer was then aliquoted into smaller tubes and stored at -86ºC [16].  
2.2.8 Demethylation assay by direct detection of formaldehyde 
AlkB mediated demethylation was analyzed by repair of different lengths of N3meC 
present in ssDNA[16]. In this assay this released formaldehyde is detected to 
estimate the AkB activity. The assay was performed in 96 well plates with the total 
reaction volume of 50µL. 0.2µM of AlkB was incubated with methylated nucleotide 
containing substrate such as M13 ssDNA containing N3meC or 70-mer oligo 
nucleotide substrate consisting of 69 thymine and single N3meC at 35th position, 
15th position or at 1st position in demethylation buffer (20 mM HEPES, pH 8.0, 200 
μM 2OG, 2 mM L-Ascorbate, 20 μM Fe (NH4)2(SO4)2, 100 μg/ml bovine serum 
albumin), at 37°C for 1 hour. Next, to quantify the formaldehyde released 40µL 
ammonium acetate (5M) and 10ul accetoacetanilide (0.5M) was added to reaction. 
Formaldehyde reacts with ammonia and acetoacetanilide to form a fluorescent 
dihydropyridine product which has excitation maxim at 365 nm and emission 
maxima at 465nm. The resulting fluorescent product was analyzed using spectral 
scanning in the wavelength range 421-521 nm with excitation wavelength of 365 nm 
using Synergy (Biotek Instrument) multimode reader. The RFU value at 465 nm was 
then converted to formaldehyde using formaldehyde standard curve. 
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2.2.9  Preparation of formaldehyde standard curve 
Formaldehyde standard curve was prepared using a range of concentration from 
0.1µM to 2µM. 40µl Ammonium acetate and 10µl acetoacetanillide were added to 
reaction mixture containing desired formaldehyde concentration in demethylation 
assay buffer. Spectral scan in the range 421nm to 521 nm was recorded. The RFU 
values at 465 nm were plotted with formaldehyde concentration to get a standard 
curve using linear regression method in graph pad prism 5.0 [16]. 
2.2.10  Demethylation assay by FDH-coupled indirect detection of 
formaldehyde 
Formaldehyde Dehydrogenase enzyme from Pseudomanas species (Sigma F1879) 
was dissolved in buffer containing 100mM HEPES pH8.0, 4mM EDTA, 6mM DTT 
and 50% glycerol. The enzyme was dissolved to a final concentration of 
0.01Units/µl. 10X stock of NAD
+ 
was prepared by dissolving it in H2O to a final 
concentration of 10mM.  Assay buffer was same as demethylation assay buffer used 
in the direct repair assay. A 100µL reaction was set up by adding DNA substrate 
1µM, AlKB 0.2µM, SSB/ SSB delta CTD 4µM, 1mM NAD
+
 and 0.01U FDH in 
assay buffer containing (20 mM HEPES, pH 8.0, 200 µM 2OG, 2 mM L-Ascorbate, 
20μM Fe(NH4)2(SO4)2,). The reaction was set up in 96 well plate and monitored for 
abs at 340nm for 1hr. A control reaction was set up wherein DNA substrate was not 
added. The control reaction was used for baseline correction [16, 17].  
2.2.11 Enzyme Kinetic analysis 
Enzyme kinetics analysis was performed by using 0.2µM AlkB and a range of 
oligonucleotide substrate concentration ranging from 0.2µM to 6.3µM. 70 mer 
oligonucleotides with internally located methylated nucleotide at 35
th
 position or 
60 
 
15
th
 position or 70 mer oligonucleotide with terminally located methylated 
nucleotide were used as substrate for enzyme kinetic analysis.  AlkB (0.2 µM) was 
mixed with the eight different concentration of SSB-bound or free 70-mer internal 
N3meC containing oligonucleotide (ranging from 0.2 to 6.3µM). The amount of 
formaldehyde released at each time point was quantified as described before [16]. 
The initial velocity was calculated by the analysis of the slope of these time course 
reactions. The velocity data were then fit to the Michaelis-Menten equation and 
Lineweaver-Burk plot to calculate Vmax (maximal velocity), KM (Michaelis 
constant) using GraphPad Prism 7.0 (GraphPad Software, Inc., San Diego, CA) [16].  
2.3 Results and discussion 
So far, all the in vitro studies of AlkB activity have been carried out either in the 
presence of very short oligonucleotide or completely protein-free ssDNA [4, 8-25] 
but never in the presence of SSB-bound single-stranded DNA. It was estimated that 
E. coli had 1000-2000 tetrameric SSB molecules per cell which are sufficient for 
stoichiometric binding of SSB molecules to all ssDNA formed predominantly during 
replication and repair [10, 26]. It was hypothesized that AlkB has to repair the SSB-
coated ssDNA in vivo. The objective was to determine whether SSB, being an 
ssDNA binding protein, hinders or promotes AlkB function. 
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Figure 5: (A) SDS-PAGE analysis of purified tagless E. coli AlkB, SSB and SSB-1-
115. (B) Size exclusion chromatography (SEC) analysis of purified SSB and SSB1-
115 (100mg). SEC was performed using Superose-12. Comparison of elution 
volume of SSB and SSB-1-115 with molecular weight standard indicates both the 
protein to be tetramer. SSB tetramer eluted (10.7 ml) ahead of SSB-1-115 tetramer 
(11 ml). 
2.3.1. SSB facilitated repair of longer ssDNA by AlkB 
To study that AlkB mediated repair activity was examined in presence of SSB-
bound ssDNA containing methylated nucleotide as substrate. It was observed that 
SSB indeed stimulated AlkB activity. SSB facilitated AlkB-mediated repair of 
longer ssDNA. Although repair of methyl adducts on ssDNA substrate by AlkB was 
reported previously, none of the earlier studies had examined SSB-bound ssDNA as 
the substrate of AlkB.  
A B 
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To investigate this question, AlkB, SSB and truncated SSB containing only the OB 
domain (SSB-1-115) without any affinity tag (Fig.5A) were overexpressed and 
purified. Size exclusion chromatography analysis revealed that both SSB and SSB-
1-115 were able to forms tetramer (Fig.5B) in agreement with the previous report 
[27]. It was demonstrated before that unstructured C-terminal domain of SSB are 
located at the periphery of the tetramer and are not involved in the interaction with 
DNA [5] . It was also found that both SSB and SSB-1-115 could bind ssDNA. The 
SSB tetramer binds ssDNA in a variety of binding modes depending on solution 
conditions, especially salt concentration. At low monovalent salt concentrations 
(<20mM NaCl), an SSB tetramer binds to approximately 35 nucleotides of ssDNA, 
known as (SSB)35 mode. However, at higher salt concentrations (>0.2MNaCl), an 
SSB tetramer binds to approximately 65 nucleotides of ssDNA, known as (SSB)65 
mode [28]. Because increasing ionic strength might affect possible AlkB-SSB 
interaction, the role of SSB in AlkB-mediated repair was studied at low ionic 
strength (10mM NaCl) throughout the study. As the substrate for in vitro repair 
variety of damaged DNA were used including MMS-damaged M13 ssDNA 
containing multiple methyl-adducts or chemically-synthesized DNA substrate of 10-
mer oligo-dT containing single N3meC at position 5 and 70-mer oligo-dT consisting 
of a single N3meC located either at the 35
th 
position or 15
th
 position. In AlkB-
catalyzed oxidative demethylation, oxidized methyl groups are released as 
formaldehyde which was measured by adding acetoacetanilide and ammonia 
directly to the repair reaction to generate a fluorescent compound with peak 
emission of 465 nm, as described previously [16]. Concentration of released 
formaldehyde was determined from the formaldehyde standard curve [29].  
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In first set of experiment, 1mg of MMS-damaged M13 ssDNA containing numerous 
randomly located methyl adducts was used as the AlkB substrate. As expected, 
AlkB (0.2µM) was able to remove the methyl adducts and formaldehyde release was 
detected (Fig.6). Next 4µM purified SSB was incubated with methylated M13 DNA 
(1µg) to form ssDNA-SSB complex and this complex was used as substrate for 
AlkB reaction. As shown in Fig. 6, significantly higher formaldehyde release was 
observed, suggesting that the repair activity was diminished when free M13 ssDNA 
was used as substrate. To rule out any stimulation due to molecular crowding effect, 
equivalent amount of BSA was added instead of SSB in the reaction mixture. As 
expected, BSA did not alter the amount of formaldehyde release (Fig.6). It was 
hypothesized that if the stimulation of AlkB activity was dependent on SSB-DNA 
interaction, then the repair would be unaffected if SSB lacking C-terminal 
disordered region was used. Indeed, when the repair reaction was carried out in the 
presence of SSB-1-115, enhanced formaldehyde released was observed (Fig. 6), 
suggesting that binding of ssDNA to SSB itself might promote the AlkB activity. 
The released formaldehyde was quantified using formaldehyde standard curve as 
shown in fig.6. Binding of large M13 ssDNA to full length or truncated SSB could 
prevent secondary structure formation and promote AlkB-mediated repair. Previous 
in vitro DNA binding experiments determined that only oligonucleotides longer than 
20 nucleotide could efficiently bind to E. coli SSB [30]. So it was hypothesized that 
shorter (<20 bases) methylated ssDNA would not be able to bind SSB and, 
therefore, DNA would be completely accessible to AlkB. Hence, if free SSB protein 
is able to stimulate AlkB activity in allosteric manner, there might be an enhanced 
repair. Therefore, shorter oligonuleotides (10- mer) containing single N3meC (2 
64 
 
mM) were used as substrate of AlkB in the presence or absence of SSB (4µM). As 
shown in Fig. 7, AlkB was able to oxidatively demethylate N3meC present in 10-
mer oligonucleotide and produce formaldehyde. Notably, the amount of 
formaldehyde released was very small compared to methylated M13 substrate. This 
could be due the large size of M13 ssDNA which is 6400 base long and methylated 
by MMS treatment and ought to have large number methylated DNA adducts. 
 
Figure 6: (A) Comparison of DNA repair by AlkB (0.2 µM) in the presence of SSB 
(4 µM). BSA (2 µM) was used as control. Methylated M13 ssDNA (1 µg) was used 
as substrate. Emission spectra depict the product of reaction between 
acetoacetanilide and formaldehyde, formed due to repair of methyl adducts. 
Formaldehyde production due to oxidative demethylation of methylated M13 
ssDNA. (B) Formaldehyde release was quantified by formaldehyde standard curve. 
Error bar 
A 
B 
65 
 
depicts the standard error.The P value was calculated by two-tailed Student's t-test 
(* indicates P < .05). 
 
Figure 7: Comparison of DNA repair using 10-mer single N3meC containing 
oligonucleotide (2µM) as substrate. Error bar depicts the standard error.  
The 10-mer and 70- mer substrate used here have single damage lesion and yield 
very low level of formaldehyde during repair. However, no stimulation of AlkB 
activity was observed in the presence of SSB. SSB-1-115 also had no effect on AlkB 
mediated repair of 10-mer N3meC containing oligonucleotide (Fig.7). This data 
suggested that when the length of ssDNA was too short for SSB binding, AlkB 
activity could not be allosterically activated by SSB.  
Next, longer oligonucleotides were used as the substrate that can bind SSB. 70-mer 
oligonucleotide with single N3meC at 35th position (2µM) was used as substrate of 
AlkB (0.2µM) in the presence or absence of SSB (4µM). As shown in Fig. 8, AlkB 
was able to oxidatively demethylate N3meC present in 70-mer oligonucleotide and 
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produce formaldehyde, albeit with lower efficiency compared to 10-mer 
oligonucleotide. However, when SSB was added stimulation of AlkB activity was 
observed. Truncated SSB lacking C terminal unstructured region (SSB-1-115) also 
resulted stimulation on AlkB mediated repair of 70-mer N3meC containing 
oligonucleotide (Fig. 8). These results were in agreement with the previous 
experimental results obtained with M13 ssDNA and indicated that both DNA 
wrapping by SSB and AlkB-SSB interaction promote AlkB activity.  
 
 
Figure 8: Comparison of DNA repair using 70-mer single N3meC containing 
oligonucleotide (2µM) was used as substrate. Error bar depicts the standard error. 
The P value was calculated by two-tailed Student's t-test (* indicates P < .05). 
2.3.2. FDH coupled indirect assay to confirm SSB promotes AlkB activity 
To further confirm that AlkB was probably inefficient in repairing large ssDNA and 
the role of SSB could perhaps be to promote AlkB activity to the normal level 
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alternate indirect assay method was used. Formaldehyde dehydrogenase (FDH) 
oxidizes formaldehyde to formate using NAD+ as the electron acceptor whose 
reduction to NADH can be measured by absorbance at 340 nm and previously used 
to monitor formaldehyde release including JmjC histone demethylase [31] and AlkB 
[17]. The reactions were initiated by adding oligonucleotide containing single 
N3meC and absorbance at 340 nm at different time points revealed production of 
formaldehyde. As shown in Fig. 9, comparable increase of absorbance at 340 nm 
was observed when N3meC containing shorter oligonucleotide (10-mer) were used, 
indicating that the presence of SSB had no influence on the amount of formaldehyde 
produced in the AlkB-catalyzed demethylation reaction. The fact that similar 
amount of formaldehyde was generated in the demethylation of 10-mer DNA 
strongly suggests that the reaction had occurred.  
 
Figure 9: Demethylation reaction using 10-mer single N3meC containing 
oligonucleotide (2µM) and AlKB (0.2µM) in the presence or absence of tetrameric 
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SSB (4µM) 4 mM, AlkB-mediated repair reaction for formaldehyde production and 
its detection by formaldehyde dehydrogenase (FDH)-coupled assay. Error bar 
depicts the standard error. 
Next, the repair reaction with 70-mer oligonucleotide (2 µM) with single N3meC at 
35th position was studied. As before, E. coli AlkB (0.2µM) was added in the 
presence and absence of SSB (4µM) and formaldehyde release was detected. 
Stimulation of AlkB activity was observed in the presence of full length SSB (Fig. 
10). Stimulation was also observed with truncated SSB lacking C-terminal 
unstructured region (SSB-1-115), suggesting that SSB-binding and protein-protein 
interaction both are responsible for stimulation of AlkB activity. These findings 
from the indirect FDH-coupled repair assay were in accord with the observations 
from the direct repair assay. 
 
Figure 10: 70-mer single N3meC containing oligonucleotide (2µM) was used as 
substrate. Error bar depicts the standard error. The P value was calculated by two-
tailed Student's t-test (* indicates P < .05). 
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2.3.3. AlkB enzyme kinetics in presence of SSB 
To further explore the mechanism of stimulation of AlkB mediated DNA repair by 
SSB, the kinetics of AlkB catalyzed reaction using 70-mer oligo-dT with single 
N3meC containing oligonucleotides was studied. For all of the experiments, 
complexe of SSB under low-salt conditions without Mg2
+
 cation which could retain 
AlkB interaction were used. Under those conditions, the binding mode of E. coli 
SSB was such that two monomers of the SSB tetramer were in contact with ssDNA 
and two SSB tetramers together could bind a 70-mer ssDNA. E. coli SSB is also 
known to translocate spontaneously and rapidly along the ssDNA via partial 
unwrapping of one end segment of ssDNA followed by re-wrapping of the other end 
in its place. So it was hypothesized that if the terminal nucleotide contained the 
methyl adducts, it might be mostly accessible to AlkB for repair compared to the 
damage nucleotide which is located internally. Therefore, while SSB-wrapping and 
AlkB-SSB interaction might be required to promote the repair of an internally 
located methyl adduct, it might be redundant for terminally located methyl adduct 
repair. First, 70-mer oligo-dT with single N3meC at the 5’-end was examined for 
repair in presence or absence of AlkB (Fig. 11). It was observed that, AlkB was able 
to repair 70-mer terminal N3meC containing oligonucleotide with a KM values 2.4 
µM. When tetrameric SSB was added to the reaction mixture, the KM remained 
almost unchanged (2.7µM), suggesting SSB had little effect on AlkB activity 
(Fig.11). Similar KM was also calculated by us using a 40-mer N3-me oligo-dC 
substrate [29], and others with 19-mer oligo containing a single N3meC [17]. These 
results indicated that N3meC positioned at the 5’-termini of SSB-bound DNA is as 
accessible to AlkB as it is in the short oligonucleotide. Next, 70-mer oligo-dT with 
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single N3meC located internally, either at the 15
th
 position or at the 35
th
 position 
was studied for repair. AlkB was able to repair 70-mer oligonucleotide with internal 
N3meC (35
th
), but with a high KM (6.7 µM) (Fig. 12). Interestingly, when SSB was 
added to the reaction mixture, the KM decreased significantly (2µM), suggesting 
strong stimulation of AlkB activity by SSB. Repair 70-mer internal N3meC (15
th
) 
was also observed but as expected with a high KM (8.2 µM) (Fig. 13). As before, 
when SSB was added to the reaction mixture, the KM reduced (1.8µM). The KM of 
15
th
 position N3meC oligonucleotide was higher than that of 35
th
 position 
oligonucleotide. It was assumed that 35
th
 nucleotide is located at the interface 
between the two SSB tetramers and could be exposed; whereas, the methylation site 
at the 15
th
 position could be wrapped by SSB.  
Table 4: Comparison of kinetic constants of AlkB  
S. No. Substrate KM (µM) Kcat (min
-1)
 Reference 
1. 30mer ssDNA 
5’CGTCGAATTN3meCTA GAGCCCC3’ 
3.4 2.2 [17] 
2. 40mer oligodC (N3meC)40 2.72 1.89 [29] 
3. T(N3meC)T 24 21 [32] 
4. 70mer oligodT with N3meC at position1 2.4 3.071  
5. 70mer oligodT with N3meC at position1 + SSB 2.7 3.050  
6. 70mer oligodT with N3meC at position15 8.2 2.42  
7. 70mer oligodT with N3meC at position15 + SSB 1.8 2.67  
8. 70mer oligodT with N3meC at position35 6.7 2.37  
9. 70mer oligodT with N3meC at position35 + SSB 2.0 2.7  
 
The kinetic experiment implied that AlkB-mediated repair of internally located 
damage of 70-mer DNA is indeed augmented by SSB as a result of increased 
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affinity for substrate binding. These results unveiled an important role of SSB in 
AlkB mediated repair of large ssDNA.  
The presence of SSB lowered the KM of AlkB catalyzed reaction and was crucial for 
efficient repair of longer substrate but may be dispensable for the small 
oligonucleotide substrate. When the length of the single-stranded DNA increased, 
the catalytic efficiency of AlkB decreased. Since longer stretch of ssDNA would 
always remain bound by SSB, AlkB can readily repairs such SSB-bound DNA. 
SSB-AlkB interaction may further promote AlkB-mediated repair. The binding 
affinity of SSB to ssDNA decreased drastically with decreasing length of the 
oligonucleotide. However, removal of methyl adducts by AlkB from very short 
patch of single-stranded region was rather efficient and therefore would be SSB 
independent. It was speculated that AlkB-mediated repair of methyl adduct would 
probably be executed without affecting any cellular process, such as replication and 
recombination, where the long stretches of ssDNA remains predominantly SSB-
bound. Thus, based on the data, it was found that wrapping of ssDNA by SSB could 
alter the ssDNA structure and melt the secondary structure that is more suitable to 
AlkB-mediated repair resulting in reduction of the KM and alleviated repair.  
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Figure 11: Kinetics of repair of SSB-bound 3meC containing 70-mer oligonuleotide 
substrate. (A) 70-mer oligonuleotide containing single N3meC at the 5’-end as 
substrate for AlkB reaction. (B) Michaelis-Menten analysis of steady-state kinetics 
for AlkB-mediated repair of free and SSB-bound 70-mer terminal N3meC 
containing oligonucleotide. AlkB (0.2µM) was mixed with various concentration of 
free oligonucleotide and SSB-bound oligonucleotide as substrate. (C) Lineweaver-
Burk transformation of the steady-state kinetics data. 
 
 
Figure 12: Kinetics of repair of SSB-bound 3meC containing 70-mer oligonuleotide 
substrate with N3meC at 35
th
 position. (A)70-mer oligonuleotide containing single 
A B 
A B 
C 
C 
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N3meC at the 35
th
 position. (B) Michaelis-Menten analysis of steady-state kinetics 
for AlkB-mediated repair of free and SSB-bound 70-mer internal N3meC oligo-dT 
(35
th
 position).(C) Lineweaver-Burk transformation of the steadystate kinetics data. 
Graphs represent averages of six experiments. Error bar depicts the standard error. 
 
 
Figure 13: Kinetics of repair of SSB-bound 3meC containing 70-mer oligonuleotide 
substrate with N3meC at 15
th
 position. (A)70-mer oligonuleotide containing single 
N3meC at the 15th position. (B) Michaelis-Menten analysis of steady-state kinetics 
for AlkB-mediated repair of free and SSB-bound 70-mer internal N3meC oligo-dT 
(15th position). (C) Lineweaver-Burk transformation of the steady-state kinetics 
data. Reactions were quantified by detecting formaldehyde released using 
formaldehyde standard plot. Curves represent nonlinear regressions to the 
Michaelis-Menten equation obtained using GraphPad Prism 7.0 software. Error bar 
depicts the standard error. 
 
In summary, it was found that AlkB inefficiently repaired longer single stranded 
DNA; however, it readily repaired SSB-bound methylated ssDNA of equal length. 
C B A 
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Considering the critical role of SSB as a platform for recruitment of DNA repair and 
recombination proteins, it was demonstrated that SSB plays crucial role in 
promoting oxidative demethylation repair. 
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Chapter 3: Interaction of AlkB with SSB 
 
3.1. Introduction 
E coli SSB is a tetrameric protein consisting of four identical subunits. Each SSB 
monomer consists of 178 amino acid residues and has three domains: N-terminal 
OB-domain (Oligonucleotide/oligosaccharide Binding) [1] that binds ssDNA 
(residues 1–115), intrinsically disordered linker (IDL) region (residues 116–169) 
and [2] C-terminal acidic domain (residues 170–178) that binds several proteins 
involved in DNA metabolism [3]. The IDL of SSB is not observable in crystal 
structures, suggesting that these C-terminal tails are intrinsically disordered. Indeed, 
the IDL displayed low sequence complexity and enriched with a large number of 
proline, glycine, and glutamine residues, resulting in highly disordered/unstructured 
characteristics. Computational analysis revealed that the IDL is essential for highly 
cooperative binding of SSB to ssDNA [4]. Beside this, no other functional 
importance of IDL is known. C-terminal acidic domain of SSB act as protein 
interaction platform and bind various replication and repair proteins including base 
excision repair pathway enzyme uracil DNA glycosylase [5], translesion DNA 
polymerases [6, 7], RecJ [8], recombination mediator RecO [9], repair protein RadD 
[10], Exonuclease- 1 [11, 12] and RecQ helicase [13]. As many DNA repair proteins 
are known to interact with SSB, the objective in this chapter is to characterize the 
direct interaction of DNA dealkylation repair protein AlkB with SSB. AlkB has 
been known to repair various alkyl adducts, including N1meA and N3meC, present 
in DNA by oxidative demethylation. Previous studies have shown that AlkB 
preferentially removes alkyl-adducts from ssDNA. Although the molecular 
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mechanism of AlkB-mediated catalysis is well-understood, it was not clear whether 
SSB is involved in direct interaction with AlkB. In this chapter, the analysis of SSB-
AlkB interaction has been done to address whether SSB can bind to AlkB. For this 
several truncated SSB construct were generated and the SSB-AlkB interaction was 
studied by yeast-two-hybrid and pull-down analysis. Surprisingly, it was found that 
that binding of SSB to AlkB involves the IDL of SSB. The C-terminal acidic 
domain of SSB, which is widely involved in protein-protein interaction, is 
dispensable for this interaction. 
3.2. Materials and method:   
3.2.1. Cloning 
For His tag expression AlkB gene was sub-cloned from pBluscript-AlkB clone No. 
151 into pET28a-1 vector using BamH1 and Sal1 sites. For GST fusion expression, 
SSB gene was cloned in pGEX-6p1 vector using BamH1 and Xho1 sites. SSB-1-115 
was cloned into pGEX-6p1 vector using BamHI and XhoI sites. SSB-116-178 was 
cloned into pGEX-6p1 vector using NcoI-EcoRI and XhoI sites. SSB-116-169 was 
cloned into pGEX-6p1 vector using NcoI-EcoRI and XhoI sites. SSB-116-151 was 
cloned into pGEX-6p1 vector using NcoI-EcoRI and XhoI sites. For Yeast two 
hybrid assay, AlkB gene was cloned into pACT2 vector using NcoI and SalI sites. 
SSB was cloned into pGBKT7 vector using NcoI and XhoI sites. SSB-1-116-178 
and SSB-1-115 were cloned into pGBKT7 vector using NcoI and SalI site and NoI 
and XhoI site respectively. SSB-1-169 was cloned in pGBKT7 vector using NcoI 
and XhoI sites. SSB-152-169 was cloned by internal deletion method. 
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Table 5: Cloning strategy for genes cloned in section 3.2.1. 
Clone Clone No. Oligo 
Sequence (5’ – 3’) 
Cloning 
sites 
pGBKT7-SSB-
1-169 
248 SSB-NcoI-Sen 
AAA ACC ATG GAG ATG GCC AGC AGA GGC 
GTA AAC 
SSBΔC8-Xho-Anti 
GCC GCT CGA GTC ACA TCG GCG GCT CGT 
TAG ACG 
Nco1 
Xho1 
pGBKT7-SSB-
1-151 
249 SSB-NcoI-Sen 
AAA ACC ATG GAG ATG GCC AGC AGA GGC 
GTA AAC 
SSBΔ26-XhoI-Anti 
AGA TCT CGA GCT ACG CGC CGC CGC TGA 
ACT G 
Nco1 
Xho1 
pGBKT7-SSB-
152-169 
250 pGBKT7_Eag1_Sen 
CTC GAC CTG CAG CGG ACG CAT AAC TAG 
CAT 
SSB del 152-169_reverse 
GCC GCC GCT GAA CTG ATT GCC ACC CTG 
CGG 
Internal 
deletion 
pGEX-6p1-
SSB-16-151 
216 SSBCTD-NcoI-EcoRI-sen 
AAA ACC ATG GAA TTC CGT CAG GGT GGT 
GGC GCT CCG GC 
SSBΔ26-XhoI-anti 
AGA TCT CGA GCT ACG CGC CGC CGC TGA 
ACT G 
EcoRI 
XhoI 
pACT2-AlkB 198 AlkB-NCOI-sen NcoI 
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AAA ACC ATG GAG ATG TTG GAT CTG TTT 
GCC GAT GC 
AlkB-SalI-Anti 
TTT TGT CGA CTT ATT CTT TTT TAC CTG 
CCT GAC GG 
SalI 
pGBKT7-SSB 220 SSB-NcoI-sen 
AAA ACC ATG GAG ATG GCC AGC AGA GGC 
GTA AAC 
SSB-XhoI-anti 
GCC GCT CGA GTC AGA ACG GAA TGT CAT 
CAT CAA AGT CC 
NcoI 
XhoI 
pET-28-a-AlkB 196 Subcloned from pBluescript-AlkB (clone No. 151)  BamHI 
SalI 
pTYB3-AlkB 253 pTYB3_AlkB_NcoI_F 
ATT AC CAT GGA AAT GTT GGA TCT GTT 
TGC CGA TGC TG 
pTYB3_AlkB_Sal1_R 
TTT TG TCG ACT TCT TTT TTA CCT GCC TGA 
CGG 
Nco1 
Xho1 
 
3.2.2. In vitro GST pull-down assay 
For GST pull-down experiments, full-length SSB and different truncated mutants of 
SSB were expressed as GST fusion proteins and AlkB was expressed as His-tag 
protein. For ssDNA-dependent interaction, 10 μM of 70-mer oligonucleotide was 
added along with His-tagged AlkB and GST-SSB. Protein complexes were then 
pulled down and analyzed by western blot with an anti-His antibody   
3.2.2.1. Purification of recombinant His-AlkB protein 
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The recombinant His AlkB soluble protein was purified by Ni-NTA affinity 
chromatography. For this, the pET28a-AlkB plasmid was transformed in BL-
21(DE3)pLysS cells. Few BL21+pET28a-AlkB transformed colonies were 
inoculated into 100ml LB-broth with 100 μg/ml ampicillin and grown on an 
incubator shaker at 37ºC at 200 rpm. The grown culture was 20-fold diluted into 2L 
fresh TB-broth with 100 μg/ml ampicillin. Incubation was carried out at 37ºC at 200 
rpm for 3 hrs. The culture was then induced with 1mM IPTG and kept for 5 hrs at 
30ºC at 200 rpm. Cells were harvested after centrifugation at 8000 rpm for 15 
minutes at 4ºC. The cell pellet was resuspended in 20ml of 50mM Tris-HCl buffer 
(pH 8.0) containing 300mM sodium chloride, 0.1% Triton-X, 1mM Imidazole and 
sonicated for 30 minutes. The sample was then centrifuged at 14,000 rpm for 20 
minutes at 4ºC to remove insoluble debris. The soluble fraction was mixed with 2ml 
of Ni-NTA resin pre-equilibrated with the same buffer and allowed to rotate in a 
rotary shaker for 4h to allow the protein to bind to the resin. The sample was then 
centrifuged at 1000 g for 5 minutes at 4ºC and the washing is carried out in 3 steps 
with 75 ml wash buffer (50 mM Tris, pH8.0, 350 mM NaCl, 0.1% Triton-X and 
5mM Imidazole). Centrifugation was carried out at 1000g for 4 minutes at 4ºC. 
Bound protein was eluted with elution buffer (10 mM Tris,pH 8.0, 100 mM NaCl, 
400 mM Imidazole). 1.5ml of elute1, 1ml of elute 2 and 1ml of eluting 3 were 
collected. All eluates were checked in 12% SDS-PAGE. 
3.2.2.2. Preparation of glutathione sepharose bead-bound GST-SSB 
The 750ml culture of BL-21(DE3)pLysS cells transformed with pGEX-SSB or 
truncated constructs of SSB: pGEX-SSB(116-178), pGEX-SSB(116-169), pGEX-
SSB(116-151), pGEX-SSB(1-115)  was grown. Cell extract was prepared by 
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sonication at 25% amplitude and pulse a 10sec for 20min. The soluble fraction was 
collected by centrifugation at 14000rpm/20min/4°C and mixed with 500μl 
glutathione-Sepharose bead slurry (GE-healthcare). The glutathione-Sepharose 
beads were allowed to interact and get saturate with GST-SSB or mutant SSB for 4h 
at 4°C on gentle rotation of 10rpm. Non-specific and loosely bound protein 
contaminants were removed by washing the medium with 10mM Tris-HCl pH 7.4, 
500mM NaCl and 0.1% TritonX. Finally, the GST-SSB bound beads were 
resuspended in 10mM Tris-HCl pH 7.4, 100mM NaCl and 5% glycerol. Using the 
same procedure, as a control, GST protein-bound glutathione beads were prepared 
by growing BL-21(DE3)pLysS cells transformed with pGEX-6p1. The quality and 
quantity of bound GST-SSB were checked by taking 20μl of protein-bound slurry in 
20μl of H2O and mixed with 20μl loading dye. The entire mixture was boiled at 
95°C for 10min and 10μl was analyzed in 10% SDS-PAGE. 
3.2.2.3. Interaction of glutathione bead-bound GST-SSB and His-AlkB 
50μl of Glutathione-Sepharose medium, saturated with GST-SSB or truncated SSB 
constructs or GST alone, was then incubated with 175μg of His-AlkB in 500ul 
interaction reaction containing 10mM Tris-HCl pH7.4, 100mM NaCl and 5% 
glycerol at room temperature for 2h. The beads were then separated by 
centrifugation 500g/5min.Non-specific and loosely bound His-AlkB was removed 
by washing three times with 1ml of phosphate buffer saline (PBS) using 
centrifugation 500g/5min. 
3.2.2.4. SDS-PAGE 
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Sample preparation: Washed beads were then resuspended in 40μl PBS and mixed 
with 40μl of 3X loading dye. 30μl of unbound and wash fractions were mixed with 
15μl of 3X loading dye. All samples were boiled at 95°C for 10min.   
Electrophoresis: 5μl of pulled fraction and 15μl of unbound/wash sample is 
separated by 10% SDS-PAGE. Staining and destaining of the gel were carried out as 
per the protocol described in section 2.2.2.6. As the sizes of GST protein (25.4kDa) 
and His-AlkB (27.6kDa) are close to differentiate background His-AlkB western 
blotting was employed. 
3.2.2.5. Western blotting 
Presence of His-AlkB was confirmed by western blotting using Anti-His antibody 
(GE healthcare). First, SDS-PAGE electrophoresis was done with 1.5μl of input His-
AlkB (0.3μg) and 7μl of pulled fractions loaded along with protein ladder in 10% 
SDS-PAGE run at 140V/70min.After electrophoresis, the separated protein bands 
were transferred to nitrocellulose membrane (Hybond-C Amersham) by using BIO-
RAD wet transfer system. Transfer cassette was assembled with the gel sandwiched 
between sheets of filter paper pre-soaked in cold transfer buffer (25mM Tris, 
192mM Glycine and 20% methanol). The electrophoresis tank was filled with 
transfer buffer and the transfer was run at constant 20 mA for 100min. After 
transfer, the membrane was stained with Ponceau. 
Ponceau-S Staining: Ponceau-S staining is a reversible staining process which, after 
analysis, can be easily removed by any salt solution. This step helps in checking the 
transfer success and locating the blot area to be developed by comparing with the 
protein ladder. After completion of the transfer, the transfer cassette was 
disassembled and the membrane was rinsed with Milli-Q water. The blot was then 
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immersed into Ponceau-S (Sigma 141194) solution (0.1% solution prepared in 5% 
acetic acid) for 1 to 2min with gentle shaking followed by washing to remove 
background stain. Ponceau stain was removed from blot by washing with PBS after 
imaging. Anti-His antibody (GE-Healthcare Amersham, 27-4710-01) was used as 
primary antibody and was used at 1:5000 dilution. The blot was incubated with the 
primary antibody for 1h at room temperature on gentle shaking. It was then washed 
with PBS thrice with 10ml of PBS and 10mins incubation. HRP-linked secondary 
antibody (Amersham ECL mouse IgG, NA931) was used as secondary antibody. 
The secondary antibody was diluted to 1:10000. The blot was immersed and 
incubated in secondary antibody solution for 1h at room temperature on gentle 
shaking. The membrane was then washed three ECL Western blotting detection 
reagents (Amersham, RPN2106) were used to detect the His-AlkB. An equal 
volume of detection solution 1 was mixed with detection solution 2 in a final volume 
of 500μl, was spread on the blot. Luminescence was detected by using SynGENE 
Gel Doc system. The images were captured in a continuous manner at different 
exposures times for total 30min. 
3.2.3.  Isothermal titration calorimetry (ITC) 
3.2.3.1. Purification of tagless AlkB 
the pTYB3-AlkB plasmid was transformed in BL-21 BL-21(DE3)pLysS cells. The 
protein was purified by affinity purification by fusing with the intein-chitin domain. 
The detailed protocol for chitin resin based protein purification has been same as 
discusses in section 2.2.1. The protein was then dialyzed in a buffer containing 
20mM Tris pH8.0, 100mM NaCl and 1 mM β-Mercaptoethanol. 
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3.2.3.2. The Peptide (ligand) for ITC 
Synthetic peptide corresponding to amino acid residues 152–169 of SSB 
(AQSRPQQSAPAAPSNEP) were obtained from GM Research Foundation Pvt. 
Ltd. The peptide was dissolved in buffer containing 20mM Tris pH8.0, 100mM 
NaCl and 1 mM β-Mercaptoethanol. 
3.2.3.3. ITC experiment 
All the ITC experiments were carried out in Microcal ITC 200 instrument at 25 °C 
while stirring at 750 rpm in 20 mM Tris–HCl, pH 8.0 containing 100 mM NaCl and 
1 mM β-Mercaptoethanol. The tag-less AlkB (50μM) protein was filled in the cell 
(280 μL). The syringe was loaded with peptide 250 mM in the same buffer as that of 
protein. The titrant peptides were injected in the cell in 20 successive injections of 2 
μL each at an interval of 180 s. The collected data was processed using origin 7.0 
software.  
3.2.4. CD‑spectroscopy 
3.2.4.1. Preparation of protein 
Purified Tagless AlkB and SSB were used for CD experiment. pTYB3-AlkB and 
pTYB3-SSB plasmids were transformed into BL-21(DE3)pLysS cells. The proteins 
were purified using standard chitin resin based purification protocol as discussed in 
section 2.2.1. The purified protein was split into two batches which were dialyzed in 
two different buffers. One batch of the proteins was dialyzed in a low salt buffer 
containing 20 mM Tris–HCl, pH 7.4 and 0.1 M NaCl. Another batch was dialyzed in 
a High salt buffer containing 20 mM Tris–HCl, pH 7.4, 0.1 M NaCl. SSB peptide 
SSB-152–169 (0.25 mM) was dissolved in buffer containing 20 mM Tris–HCl, pH 
8.0, and 50 mM NaCl. 
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3.2.4.2. CD-experiment 
The CD experiments were conducted on a JASCO J-1500 instrument. A quartz cell 
of 1 mm path length was used for all the experiments. To examine the effect of NaCl 
on the AlkB and SSB conformation, CD spectra was recorded with SSB (20 μM) 
and AlkB (20 μM). Spectra were obtained at room temperature. Before measuring 
the spectra of proteins, a baseline was recorded for each of the proteins using the 
protein dialysis buffer or the dilution buffer.  CD spectra of SSB-152–169 peptide 
(0.25 mM) was measured in buffer containing 20 mM Tris–HCl, pH 8.0, 50 mM 
NaCl. The CD spectra were recorded in the far-UV wavelength range of 190-260nm. 
Before, measuring CD spectra, the CD machine was infused with nitrogen gas for 
10minutes. The baseline was loaded before running the sample spectra. The spectra 
were recorded as an average of five spectral scans with bandwidth 1 nm, step 1 nm 
and 0.5 sec/point. The data pitch was kept 0.5 nm and scanning speed was 50 
nm/sec. The recorded data were analyzed using spectra manager software. 
3.2.5. Yeast two-hybrid analysis of AlkB and SSB interaction 
3.2.5.1. Yeast strain: 
The yeast two-hybrid reporter strain, PJ69-4A (MATa, trp1-901, leu2-3, 112ura3-52 
his3-200 gal4Δ, Yeast strain: gal80Δ, LYS2:: GAL1-HIS3, GAL2-ADE2, met2:: 
GAL7-lacz) [14] was used for the yeast-two-hybrid study. 
The yeast strain possess three marker genes ADE2, HIS3 and lacZ reporter genes 
that are expressed only when a functional Gal4 protein is reconstituted by an 
interaction between the activation domain and the DNA binding domain fusion 
proteins. GAL4 Activation domain was fused with AlkB (pACT2-AlkB), and the 
binding domain was fused with SSB, (pGBKT7-SSB), for yeast two hybrid assay. 
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Different truncated constructs of SSB SSB-1-115, SSB-16-178, SSB-116-169, 
SSB116-151 and SSB-152-169 were also created as pGBKT7 fusion construct. The 
pACT2-AlkB (activation domain) plasmid was cotransformed with pGBKT7-SSB, 
pGBKT7-SSB-116-177, pGBKT7-SSB-1-115 (binding domain) , pGBKT7-SSB-1-
169, pGBKT7-SSB-1-151, and pGBKT7-SSB-152-169 plasmid into yeast strain 
pJ69-4A to generate strain J69RA1 (pACT2-AlkB + pGBKT7-SSB), J69RA2 
(pACT2-AlkB + pGBKT7-SSB-116-177), J69RA3 (pACT2-AlkB + pGBKT7-SSB-
1-115), J69RA4 (pACT2-AlkB + pGBKT7-SSB-1-169), J69RA5 (pACT2- AlkB + 
pGBKT7-SSB-1-151), J69RA6 (pACT2- AlkB + pGBKT7-SSB-152-169) and 
J69RA7 (pACT2- AlkB + pGBKT7-SSB-170-178).  
3.2.5.2. Media preparation 
As PJ69-4A strain is deficient in adenine biosynthesis, it was maintained on YPAD 
medium (2% Tryptone, 2% Dextrose, 1% Yeast Extract, and 0.1mg/ml adenine 
sulfate). On YPAD media, lacking adenine, the PJ69-4A colonies appeared red in 
color. The pACT2 vector contains LEU2 marker and pGBKT7 is with TRP1 marker. 
For selecting co-transformed PJ69-4A strains, the synthetically defined (SD) media 
lacking Leucine and Tryptophan was used. It was prepared by mixing 2.67% of 
DOB growth medium (Drop Out Base, Himedia, G082), 0.64mg/ml CSM w/o LEU 
TRP (Complete Supplement Mixture, Himedia, G115) and 1.5% agar. The media 
was sterilized by autoclaving at 115°C for 20min.  
3.2.5.3. Yeast transformation 
 Single colony was inoculated in 5 ml of YPAD broth (Yeast extract-1%, Peptone-
2%, Glucose-2% and Adenine sulfate-0.1mg/ml). The culture was incubated at 30ºC 
/200 rpm/overnight. Overnight grown pre-inoculum was then 50-fold diluted (500μl 
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into 25ml YPD-broth) and further incubated at 30ºC /200rpm/4h (should allow 2 
divisions). After the incubation cells were pelleted by centrifugation at 3000g/5min 
at room temperature (all the spin conditions were carried out at room temperature). 
The pelleted cells were washed with 10 ml of autoclaved water and harvested by 
centrifugation at 3000g/5min. The pellet was then resuspended in 500μl of 100mM 
LiOAc (Sigma, Cat.no.L6883) and split into five aliquots of 100μl each into a 2ml 
tubes. The cells were then pelleted at top speed for 20sec and the supernatant was 
discarded. To the pelleted cells a, transformation mixture was added in the following 
sequence: 2μl (100ng) of plasmid DNA, 36μl of 1M LiOAc, 25μl of heat denatured 
salmon sperm DNA (Sigma, Cat.no.D1626), 240μl of 50% PEG (Sigma, 
Cat.no.P4338). Carrier DNA was converted to single stranded DNA by heating at 
95ºC for 5min and immediately chilling on ice. After addition of all the reagents the 
transformation mixture was vortexed vigorously for a minute and then incubated in 
30°C incubator for 30min. Heat treatment was given at 42°C for 25min in water-
bath (Lauda, Version RA). Following the heat shock, cells were pelleted by 
centrifugation at 8000 rpm for 1 min and resuspended in 300μl of autoclaved water. 
The cells were finally plated on SD w/o LEU-TRP agar plate incubated at 30°C for 
2-3 days till the isolated colonies appeared. The grown isolated colonies were re-
streaked on selective media and grown for further screening by PCR based gene 
amplification. 
3.2.5.4. Yeast two-hybrid analysis 
The pACT2-AlkB plasmid was co-transformed with pGBKT7-SSB constructs 
plasmids into yeast strain pJ69-4A to generate strain J69RA (pACT2-AlkB + 
pGBKT7-SSB). The transformants were plated onto synthetically defined (SD) 
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growth medium w/o LEU-TRP (Himedia) plates and incubated at 30°C for 2–3 
days. As a control, pACT2 vector was co-transformed to pGBKT7 and pGBKT7-
AlkB. Similarly, pACT2-AlkB was transformed to pGBKT7 vector. The 
transformants were screened for interaction by using HIS3 reporter and lacZ reporter 
system. 
3.2.5.5. HIS3 selection for interaction positive cells 
Single colonies, from all the transformants grown on SD w/o Leu-Trp, were 
resuspended into 100μl of autoclaved water and 10μl spotting was performed onto 
SD w/o Leu-Trp-His plates. The plates were incubated at 30°C for 3-5 days and 
examined for the growth. A similar pattern of spots was carried on SD w/o Leu-Trp 
and used as control plate.  
3.2.5.6. Colony lift filter assay using lacZ reporter 
The β-galactosidase (β-gal) activity was measured according to the Yeast Protocols 
Handbook (Clontech). All the transformants were spotted on SD w/o Leu-Trp media 
and grown for three days at 30°C. Two autoclaved filter papers (Whatman No. 5) 
was taken and cut in the size of the Petri plate. One filter paper was presoaked in 5 
ml Z buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 
40mM β- mercaptoethanol) containing 8mg/ml X-gal. A stock of Z-buffer 
containing 60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4 without 
β-mercaptoethanol and X-gal was autoclaved and stored at 4°C. β-mercaptoethanol 
and X-gal were freshly added whenever required. Other filter paper was used to lift 
the cells by placing on the surface of grown media plate. To help colonies to cling to 
the filter, the side of the forceps was gently rubbed on the filter. Filter carrying 
transferred cells was carefully lifted and dipped in liquid nitrogen for 1min and then 
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thawed at room temperature. This step makes cells porous and helps in β-
galactosidase and X-gal interaction. After thawing, the filter disc was placed on the 
pre-soaked filter containing X-gal, facing cells upward, and incubated at 30°C till 
the blue colour developed. The appearance of blue color was monitored for 30min to 
10hr and documented by scanning the filter paper under the scanner. 
 
3.3. Result and discussion 
3.3.1. Characterization of the direct interaction of AlkB with SSB by Yeast-
two-hybrid assay 
In order to characterize AlkB-SSB interaction, several deletion constructs were 
generated as shown in Fig. 14. First, the DNA binding (OB) domain (SSB-1-115) 
was separated from the disordered C- terminal domain (SSB-116-177).  It has been 
reported that C-terminal 26-residues of SSB was important for the characterization 
of SSB- χ protein interaction [15]. Hence, SSB-1-151 lacking C-terminal 26 residues 
were created. However, a later crystal structure of the χ-SSB interaction site 
revealed the C-terminal 8 residues of SSB was the true interaction domain [153]. 
Therefore SSB-116-169 which would retain the entire structurally disordered region 
except for the terminal 8 acidic amino acid-rich segment and SSB-116-151 which 
would lack C-terminal 26 amino acid were also generated. In order to further 
confirm if SSB actually interacted with via the C-terminal 8 amino acids or the 
remaining 18 residues, SSB-170-178 and SSB-152-169 respectively were also 
created. 
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Figure 14: (A) Schematic representation of various SSB deletion constructs which 
were generated for Yeast-two-hybrid study. (B) SSB-AlkBinteraction analysis by 
yeast two-hybrid system. Positive interactions are indicated by growth on media 
lacking histidine and expression of β-galactosidase 
 
To assess whether AlkB can directly interact with SSB without the involvement of 
any intermediate proteins, yeast two-hybrid analysis was performed. E. coli SSB and 
alkB genes were cloned into vectors pGBKT7 (TRP1 marker) and pACT2 (LEU2 
marker) rendering SSB fusion with DNA binding domain and AlkB fusion with 
transcription activation domains of the Gal4 transcription factor. The direct 
interactions of fusion partners were investigated by expression of all the reporter 
genes (HIS3, and lacZ). PJ69-4A cells carrying plasmid pair pACT2- 
AlkB/pGBKT7-SSB grew on media lacking leucine, tryptophan, and histidine and 
showed a blue color on media supplemented with X-gal, suggesting direct AlkB-
SSB interaction as shown in fig.14. This result indicated that AlkB and SSB directly 
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interact with each other in the cellular context. To identify if the N-terminal DNA 
binding OB domain or the C-terminal domain of SSB interacts with AlkB, SSB-116-
178 and SSB-1-115 constructs were studied. As shown in Fig. 14, only pACT2-
AlkB/pGBKT7-SSB-116-178 grew well on media lacking histidine and showed a 
blue colour on media containing X-gal, suggesting AlkB interaction domain is 
located within the 116-178 amino acid residues of SSB and not within the N-
terminal OB domain. Within this C- terminal half of SSB, there are two domains, (1) 
IDL (residues 116-169) and (2) acidic region (residues 170-178). If the acidic 
domain is involved in binding AlkB, then a truncated form of SSB without these 
residues will not be able to interact with SSB. PJ69-4A cells expressing AlkB and 
SSB-1-169 which lacks the last 9 amino acids grew on media lacking histidine, 
suggesting that the acidic region is not involved in binding. However, SSB-1-151 
which lacks the last 27 amino acids failed to grow on media lacking histidine, 
suggesting that the region involved in binding must be located between the amino 
acid 152 and 169. To confirm this interaction domain more precisely, the growth of 
pACT2-AlkB/SSB-152-169 was examined on media lacking histidine. It was 
observed that SSB-152- 169 supported the growth, suggesting that the 18 amino acid 
residues, corresponding to amino acid residues 152-169 and located in the IDR, 
could be involved in the interaction. 
3.3.2. Verification of SSB-AlkB interaction in vitro 
To independently verify the SSB-AlkB direct interaction in vitro, the GST-pull 
down assay was performed. In this experiment, AlkB protein was expressed with 
His-tag and SSB protein was produced as a GST-fusion, which could be pulled 
down using glutathione-sepharose beads. The in vitro pull-down results show that 
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His-tagged AlkB protein was bound to GST-SSB (Fig. 15A, lane 2), but not to GST 
alone. These results suggest that AlkB and SSB made direct contact in vitro. Having 
established in vitro interaction of SSB with AlkB, the next objective was to know 
which part of the unstructured C-terminal region of SSB is involved in the 
interaction. The entire C-terminal domain (SSB-116-177), or the same domain 
lacking C-terminal 8 amino acids (SSB-116-169) or 26 amino acids (SSB-116-151) 
was expressed as GST-fusion protein. SSB construct containing only DNA binding 
OB domain (SSB-1-115) was also generated. To study in vitro interaction, purified 
His-tagged AlkB was mixed with GST-SSB-116-169, GST-SSB-116-151, and GST-
SSB-115 and pull-down experiments were performed as before. Western blot 
analysis revealed that AlkB could indeed bind to GST-SSB-116-177 and GST-SSB-
116-169 but not with GST-SSB-116-151 and SSB-1-115 as shown in Fig.17B. 
Based on this in vitro interaction result together with the yeast two-hybrid data, the 
residues 152-169 of SSB were mapped as the AlkB-interacting region. 
 
 
Figure 15: (A) GST pull down experiment of SSB AlkB interaction. (B) GST-SSB 
fusion proteins used for mapping the AlkB-interacting regions on SSB. Top: inputs 
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and pull downs were separated by SDS-PAGE and analyzed by western blot with 
anti-His antibody. Bottom: ponceau-S staining. 
 
3.3.3  Examination of the strength of AlkB-SSB interaction 
The strength of SSB-AlkB interaction was also examined by performing a pull-
down experiment in the presence of increasing concentration of NaCl. As shown in 
Fig. 16 the association of AlkB with SSB was not salt-stable and NaCl interrupted 
the binding. However, when ssDNA was included in the interaction mixture, SSB-
AlkB interaction was more stable. 10µM of 70-mer single stranded oligonucleotide 
DNA was added to His-tagged AlkB. SSB-AlkB interaction remained intact at 0.5M 
NaCl suggesting that ssDNA may render the complex more resistant to high salt 
washes. 
The effect of NaCl on the confirmation of AlkB and SSB was also examined by 
using CD   spectroscopy. As shown in Fig. 17, the CD spectra of SSB remained 
almost unchanged in the presence 1.0 M NaCl. This result is in agreement with an 
earlier report suggesting that tetrameric SSB is resistant to NaCl-dependent 
conformational changes [17]. The confirmation of AlkB protein was also analyzed 
using CD spectroscopy. E.coli AlkB CD spectrum was reported to have a 
characteristic negative peak at 214 nm [18]. This negative peak was also observed at 
100 mM NaCl. However, at a higher salt concentration (1.0 M NaCl) this negative 
peak was absent indicating some conformational changes in the AlkB structure. 
Taken together, these results suggest that SSB-AlkB interaction is facilitated by the 
presence of ssDNA in low ionic strength condition. 
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Figure 16: (A) GST pull-down experiments with His-tag AlkB and GST-tagged 
SSB proteins in presence of varying NaCl concentration to determine the effect of 
salt concentration on AlkB-SSB interaction. (B) Effect of presence of ssDNA on 
SSB-AlkB interaction studied by adding 10µM of 70-mer ssDNA to the GST-pull 
down assay. 
 
To further, characterize the strength of the interaction between residues 152-169 of 
SSB and AlkB, ITC was used. First, the intrinsically disordered nature of the peptide 
was confirmed by CD analysis. The peptide corresponding to residues 152-169 
peptide exhibited a negative minimum close to 200 nm and a relatively low 
ellipticity above 210 nm (Fig. 18), a typical observation for disordered proteins 
[154, 155]. Subsequently, ITC experiment was performed with this SSB peptide 
(residues 152-169) and AlkB. The best fit obtained with a two-site binding model, 
suggesting a high-affinity site (Kd = 0.15µM) and a very low-affinity site (Kd = 
0.45mM). As shown in Fig.19 the result from ITC experiment demonstrated that 
AlkB binds to an SSB-152-169 peptide, albeit weakly. 
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Figure 17: Circular dichroism (CD) analysis of (A) SSB and (B) AlkB in the 
presence of low (0.1 M) and high (1.0 M) concentration of NaCl. 
 
 
  
 
 
 
 
Figure 18: Conformational analysis of SSB peptide 152-169 using CD. 
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Figure 19: Binding of SSB peptide 152– 169 to recombinant AlkB was carried out 
using ITC. The top panel represents the raw data from the titration as a series of 
peaks corresponding to the heat change (μcal/s) with each injection. The bottom 
panel is heat change on ligand addition (kcal/mole) against the peptide:AlkB molar 
ratio. 
 
In summary, this chapter identified a new binding site and a new binding partner for 
E.coli SSB protein. It was shown that an 18 amino acids (152-169) region of SSB 
located within IDR is involved in the AlkB interaction. The role of the C-terminal 
acidic domain of SSB as a platform for the recruitment of DNA repair and 
recombination proteins is well established. Considering the site of AlkB-SSB 
interaction being at IDR of SSB, It has been speculating that the C-terminal acidic 
domain of SSB would remain free for other protein-protein interaction. 
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Identification of IDR of SSB as protein interaction site opens up the possibility that 
many other proteins might also interact with SSB via this site. 
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Chapter 4: Screening and evaluation of indenone derivatives as 
AlkB inhibitors 
 
4.1 Introduction 
Alkylating agents induce DNA alkylation damages that can affect genomic stability, 
cellular viability and lead to diseases such as cancer and aging. DNA alkylation can 
lead to the modification of Nitrogen and Oxygen atom of the DNA base and result in 
the formation of N-alkylation or O-alkylation lesions, respectively. N-alkylated 
DNA adducts are repaired by Fe(II)/2OG-dependent dioxygenases. These enzymes 
activate oxygen for incorporation into an alkyl group and also involve an iron (Fe
2+
) 
as co-factor and the co-substrate 2-oxoglutarate (2OG) ultimately releasing the alkyl 
group as formaldehyde and restoring the damaged DNA [1].  Escherichia coli AlkB 
is one of the most well characterized member of the family of Fe(II)/2OG-dependent 
dioxygenases [2]. AlkB homologs have been found to be present in almost all 
organisms including human [3]. E. coli AlkB acts preferably on ssDNA and RNA 
and its primary substrates are N1meA and N3meC [4, 5]. Extensive efforts have 
been made for selectively inhibiting DNA repair activity of AlkB family of 
dioxygenase [6-8]. Since there are several crystal structures of full-length AlkB 
available with various substrates and the enzyme structure and catalytic mechanism 
has been thoroughly studied, selective inhibitor of AlkB can be useful in further 
understanding the reaction mechanism. The objective of the chapter was to screen a 
library of indenone analogs for finding an inhibitor of AlkB. Since indenone 
skeleton is found in a wide range of bioactive compounds and natural products as 
discussed in section 1.8. indenone analogs were screened for inhibiting AlkB 
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demethylation activity. The library of indenone analogs was synthesized by Prof. FA 
Khan’s lab, Dept. of Chemistry, IIT Hyderabad.  
4.2. Materials and method 
4.2.1 Cloning 
AlkB was cloned into pTYB3 plasmid as described in section 2.2.1. 
4.2.2. Purification of recombinant AlkB 
Tagless AlkB protein was expressed in BL-21(DE3)plysS cells by transformation of 
the pTYB3-AlkB plasmid. The purification protocol followed was same as 
discussed in section 2.2.2. The purified protein was then dialyzed in a buffer 
containing 20mM Tris pH8.0 and 300mM NaCl. 
4.2.3.  Preparation of methylated DNA substrate 
Desalted oligonucleotide 40mer polydT with single C was purchased from Imperial 
Lifescience. Methylation adducts were generated by treating the oligonucleotide 
with MMS (Sigma, 129925). 40μg ssDNA oligonucleotides was incubated with 5% 
(v/v) (0.59 M) MMS, 200 mM K2HPO4 in 500μl of total reaction at room 
temperature overnight for 14-15 hours. MMS was then removed by dialysis against 
TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) using Spectra/Por dialysis 
membrane (MWCO: 1000) for around 10 hours, with three changes of dialysis 
buffer. The dialysis was done at 4ºC in ice-cold buffer. Then the damaged substrate 
was precipitated by adding 0.3 M sodium acetate pH 5.2 and 1 volume of ice-cold 
Iso-propanol. The precipitated ssDNA was washed with ice cold 80% ethanol and 
finally dissolved in molecular grade water. [9] 
 
 
106 
 
4.2.4. Screening of Indenone analogs for AlkB inhibition 
In vitro screening of compounds for AlkB inhibition was carried out with purified 
tag-less AlkB protein. 0.2µM of AlkB was incubated with 50µM of different 
compounds dissolved in DMSO at 37°C for 1h in reaction buffer (20mM Tris-HCl 
pH 8.0, 0.2mM 2OG, 20µM Fe(NH4)2(SO4)2, 2mM L-Ascorbate). 1µM of the 
substrate (single-stranded 40 mer oligonucleotide DNA containing single N3-meC) 
was then added to the AlkB reaction mix and incubated for 1 hour. The released 
formaldehyde was directly quantified by direct repair assay where the reaction of 
released formaldehyde with acetoacetanillide in presence of ammonia leads to the 
formation of an enamine-type fluorescent intermediate (Amax 365nm, Emax 
465nm) [9]. 50μl demethylation repair reaction product was mixed with 40μl of 5M 
ammonium acetate and 10μl of 0.5M acetoacetanillide (final volume 100μl). After 
15min, fluorescence spectra were measured in the wavelength range of 421 to 521 
nm, with excitation wavelength 365nm. The RFU values at excitation maxima 
(465nm) were used to quantify released formaldehyde using standard curve. The 
assay was performed using a 96-well microplate and Synergy (Biotek Instrument) 
multimode reader. 
4.2.5. Determination of IC50 
Different concentrations of indenone compounds ranging from 0.5µM to 1000µM 
were dissolved in DMSO and added to AlkB demethylation reaction mix. 1.5µl of 
6.5µM AlkB was incubated in 5ul reaction buffer (20mM Tris-HCl pH 8.0, 0.2mM 
2OG, 20µM Fe(NH4)2(SO4)2, 2mM L-Ascorbate) and incubated at 37ºC for 60 min. 
The reaction was initiated by adding 5µl of the 10µM substrate followed by further 
incubation of 1hr at 37ºC. The total reaction volume was 50µL. The formaldehyde 
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generation was determined as described before by using fluorescence-based method 
for direct detection of formaldehyde. The initial velocity V0 was measured for each 
reaction and plotted against compound concentrations in order to determine the IC50 
values using GraphPadPrism software. 
4.2.6. CD-spectroscopy 
Protein AlkB was dialyzed in a buffer containing 10mM Tris-HCl pH7.4 and 50mM 
NaCl for CD spectroscopy. The ligand (compound 3o) was also diluted in the AlkB 
dialysis buffer to reduce the final DMSO concentration to 0.1% for the purpose of 
CD spectroscopy. 1:1 ratio of AlkB and the compound 3o was used for the CD 
spectroscopy. 12µM of AlkB and 12µM of compound 3o were mixed in assay buffer 
comprising 10mM Tris-HCl, pH 7.4 and 50mM NaCl and incubated for 1 hour at 
room temperature. CD spectra were recorded for both far UV CD in the wavelength 
range of 190nm to 160nm and near UV CD in the wavelength range of 240-360nm 
using a 1mm path length quartz cell. CD spectra were also recorded for the protein 
AlkB and compound 3o individually. Since the compounds were dissolved in 
DMSO, it was added in all the three samples ie. AlkB or compound 3o or AlkB + 
compound 3o to the final concentration of 0.1%. CD spectroscopy was done using 
JASCO J-1500 instrument. The CD machine was infused with nitrogen gas for 10 
minutes. A baseline was recorded for each of the samples which were the dilution 
buffer for that sample. The baseline was loaded before running the sample spectra. 
The spectra were recorded as an average of five spectral scans with bandwidth 1nm, 
step 1nm and 0.5sec/point. The data pitch was kept 0.5nm and scanning speed was 
50nm/sec. The recorded data were analyzed using spectra manager software. 
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4.2.7. Isothermal titration calorimetry (ITC) 
ITC experiments were done using ITC Microcal-200. 10µM of AlkB was added to 
the ITC cell in buffer containing 50mM Tris-HCl pH8.0, 100mM NaCl and 10mM 
β-mercaptoethanol. Compound 3o or 3a or 3j at 100µM was added to the syringe. 
The ligand was injected into the cell with 20 consecutive injections of 2 µl each with 
2 min intervals between successive injections. The syringe was being rotated at 600 
rpm. The heat pulse obtained for each titration was fitted using MicroCal Origin 7.0 
software. The one-site binding model was used to calculate the corresponding 
dissociation constant. 
4.2.8. Enzyme kinetics 
Purified recombinant AlkB (0.2 µM) was mixed with the eight different 
concentration of 40-mer internal N3me-oligo-dC (ranging from 0.12-3.8µM) in 
reaction buffer (20mM Tris-HCl pH 8.0, 0.2mM 2OG, 20µM Fe(NH4)2(SO4)2, 
2mM L-Ascorbate). Reactions were also performed in presence of 50, 100, 250 and 
500µM of compound 3o. The enzyme was mixed with compounds for 1h and the 
reaction started by adding the substrate. The amount of formaldehyde released at 
different time point was quantified using direct repair assay. The initial velocities 
after addition of the compounds were calculated by the analysis of the slopes of time 
course reactions. The initial velocity data were then fit to the Michaelis-Menten 
equation to calculate Vmax (maximal velocity), KM (Michaelis constant) using 
GraphPad Prism 7.0 (GraphPad Software, Inc., San Diego, CA). Transformation of 
Michaelis-Menten to Lineweaver-Burk plot was also carried out by GraphPad Prism 
7.0. 
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4.2.9. Molecular Docking 
Protein structure 3i49 was used for AlkB docking. Autodock-4.0 was used for 
docking 3o to and AlkB. 3D structure of the ligands was prepared using the 
MarvinSketch software. The geometry optimization and energy minimization of 
ligands were carried out using an MM94 force field. The protein structure was 
prepared by adding Hydrogen atoms followed by removal of all the water 
molecules, using Autodock-4.0. Kollman charges were added to protein prior to 
docking using Autodock tools. The compound 3o was docked to AlkB blindly using 
standard rigid docking protocol. The grid box dimensions were 30 X 30 X 30 with 
grid box center at (14.268, 13.335, -7.861) and spacing of 0.3Å. Analysis of the 
docked structures and evaluation of binding energy was done using analysis tool of 
Autodock suite. Visualization of the docked structure of protein-ligand and 
comparison of the docked positions of different ligands was done using Discovery 
studio visualizer. 
4.2.10. Cell survival Assay 
A single colony of wild-type E.coli or AlkB mutant strain HK-82 was inoculated in 
5ml autoclaved LB broth at 200rpm for 14-16hours to obtain the primary culture.  
10 ml of fresh LB broth was then inoculated with 1% primary culture. The culture 
was allowed to grow at 37ºC, 200rpm till it reached early log phase. The optical 
density of the culture was measured at 600nm using a spectrophotometer. Fresh LB 
medium was used as a blank. The culture was grown till the OD reached ~ 0.2. The 
culture was then transferred to 96-well plates, with 200uL of culture in each well. 
MMS was added to each well to the final concentration of 0.01%. Compound 3o 
was also added to the culture in 96 well plates to the final concentration of 50uM. 
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The 96-well plate was incubated at 37ºC, 200rpm for 5hours. Optical density at 
600nm was recorded every hour using the multimode reader. The experiment was 
repeated 5 times independently and the mean value was considered. 
4.2.11. Effect of compound 3o on MMS sensitivity 
A single colony of wild-type E.coli was inoculated in 5ml autoclaved LB broth at 
200rpm for 14-16hours to obtain the primary culture.  10 ml of fresh LB broth was 
then inoculated with 1% primary culture. The culture was allowed to grow at 37ºC, 
200rpm till it reached early log phase. The optical density of the culture was 
measured at 600nm using a spectrophotometer. Fresh LB medium was used as a 
blank. The culture was grown till the OD reached ~ 0.2. The culture was then 
transferred to 96-well plates, with 200µL of culture in each well. MMS was added to 
each well to the final concentration of 0.01%. Different compounds (3a-3q) were 
added to the culture in 96 well plates to the final concentration of 50 µM. The 96-
well plate was incubated at 37ºC, 200 rpm for 5 h. Optical density at 600nm was 
recorded every one hour using the multimode reader. The experiment was repeated 5 
times independently and the mean value was considered. Relative survival 
percentage was calculated by using OD of the No treatment well as 100 % survival. 
The experiment was repeated 5 times independently and the mean value was 
considered.  
4.3. Result and discussion 
4.3.1.  Evaluation indenone compounds as an inhibitor of DNA demethylation 
repair protein AlkB 
The library of seventeen 2-Chloro-3-Amino indenone compounds (Fig.20) was 
screened for their inhibitory effect on the activity of E.coli AlkB. Recombinant 
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AlkB was used for this study using direct repair assay where formaldehyde released 
over time was monitored. The screening assay was set up with 1µM of MMS-
damaged 40-mer oligonucleotide (T20 3meC T19) consisting of single N3meC as a 
substrate for 0.2µM AlkB and 50µM of each of the indenone compounds were 
added in the DNA repair reaction with final volume 50µL. Fig. 21 represents the 
results of the screening. It was found that most of the compounds showed no 
inhibitory effects, however, a few compounds affected AlkB activity significantly. A 
compound was considered to have an inhibitory effect on the AlkB activity when the 
formaldehyde release was measured less than 20% of the control AlkB activity 
wherein only DMSO was added to the AlkB repair reaction Compound 3o was 
found to be a primary hit for AlkB inhibition from the initial screening of 17  
 
Figure 20: Library of 17 Indenone analogs screened for inhibition of AlkB 
demethylation activity. 
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Figure 21:  Screening for inhibition of AlkB activity with 17 indenone compounds, 
arranged in the descending order of activity. Effect of these compounds on AlkBH3 
activity is also shown for comparison. Error bars depict the standard error. 
 
Table 6: Library of indenone compounds screened for AlkB inhibition 
Structure Molecular weight Compound No. 
 
207.65 3a 
 
235.70 3b 
 
249.73 3c 
 
233.69 3d 
113 
 
 
305.84 3e 
 
283.75 3f 
 
283.75 3g 
 
287.71 
 
 
 
3h 
 
299.75 3i 
 
269.72 3j 
 
283.75 3k 
 
297.77 3l 
114 
 
 
311.80 3m 
 
295.76 3n 
 
334.84 3o 
 
345.82 3p 
 
349.78 3q 
 
compounds. Compound 3o was also evaluated for inhibition of AlkBH3 activity to 
determine its specificity. As shown in Fig. 21 AlkB inhibition was found to be 
specific as the activity of Human AlkBH3 was not altered by compound 3o. 
 
4.3.2. Conformational and binding analysis of AlkB and 3o. 
The ability of the compound 3o to form a complex with AlkB was evaluated by 
Isothermal titration calorimetry (ITC). To rule out the possibility that the observed 
energy changes could be non-specific and are not due to AlkB and compound 3o 
interaction, control ITC experiments were performed with compounds 3a and 3j 
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which are structurally similar to 3o. The raw ITC data and the one-site model fit are 
shown in Fig.22(A). It was found that the inhibitory activity of compound 3o is due 
to direct interaction with AlkB. Parameters derived from ITC showed that 3o is a 
tight binding ligand for AlkB with a dissociation constant of 3.3µM. Analysis of 
thermodynamic parameters revealed that binding of 3o resulted in favorable 
enthalpy change (ΔH<0) and unfavorable entropy change (ΔS<0). These results 
indicated favorable electrostatic, H-bonding and van der Waals interactions between 
the AlkB protein and the compound 3o. The data for compounds 3a and 3j showed 
that these molecules did not bind to AlkB Fig.22(B and C). 
The CD spectra of AlkB in presence of compound 3o was also analyzed to 
determine if there are any changes in the local tertiary structure upon 3o binding. 
The results of the CD spectroscopy are shown in Fig. 23. Comparison of the far-UV 
CD spectra of AlkB and AlkB-3o showed that the spectrum of AlkB-3o differed 
from that of AlkB with respect to CD signal at 208 nm and 222 nm which indicate a 
slight alteration in the alpha helix content of AlkB when 3o was bound to AlkB. A 
reduction in positive signal at 195nm was also observed when 3o was bound to 
AlkB which implied an alteration in the total beta helix content. These results 
indicated alterations in the characteristic jelly-roll fold formed by beta sheets.  The 
near UV CD spectra of AlkB was also analyzed in the presence or absence of 
compound 3o.  
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Figure 22: Binding analysis. (A) Isothermal titration calorimetry (ITC) to determine 
to bind of compound 3o, (B) 3a and (C) 3j to recombinant AlkB. The top panel 
represents the raw data from the titration as a series of peaks corresponding to the 
heat change (μcalories/s) with each injection. The bottom panel is a plot of heat 
change on ligand addition (kcal/mole) against the compound/AlkB molar ratio. The 
data was fitted using one-site binding model in the microcal data analysis software 
package in Origin (origin labs). 
 
 
Figure 23: Conformational analysis of AlkBH3-3o interaction by circular dichroism 
(CD). (top) Far-UV CD spectra (between 190nm and 260nm) for AlkB (solid line) 
B A C 
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or AlkB with compound 3o bound (dotted line). (bottom) near-UV CD spectra 
(between 240nm and 360nm) for AlkB (solid line) or AlkB with compound 3e 
bound (dotted line). 
 
Analysis of near UV spectra revealed changes in the overall tertiary conformation of 
AlkB upon binding of compound 3o. Since compound 3o is an achiral molecule, no 
CD signal was observed from 3o alone. Also, AlkB lacked disulfide bonds so, the 
near UV CD signal was obtained by aromatic amino acids tryptophan (290-300nm), 
tyrosine (270-280nm) and phenylalanine (250-270nm).  
4.3.3. Mechanism of inhibition of AlkB 
The IC50 value was determined to assess the inhibitory potential of compound 3o. 
Increasing concentration of the compound 3o was added to the AlkB reaction 
mixture. The results are shown in Fig. 24. IC50 value for compound 3o was found to 
be 19.37µM. 
 
Figure 24: IC50 data of compounds 3o against AlkB. 
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The steady-state enzyme kinetics was performed next, to find out the mode of 
inhibition. The initial velocities of AlkB in presence of different concentrations of 
3o were determined and fitted to double reciprocal Lineweaver-Burk plot. It was 
found that the Vmax remained unchanged in presence of 3o which implied a 
competitive mode of inhibition (Fig. 25A).The initial velocities of AlkB were also 
analyzed by varying concentration of the co-substrate 2OG while keeping a fixed 
saturating concentration of DNA substrate. It was observed that there was a gradual 
decrease in Vmax upon increasing the concentration of 3o. Also, the intersection 
point of the lines corresponding to different concentrations of 3o was above the y-
axis in the Lineweaver-Burk plot (Fig. 25B). These results indicated that there is 
mixed inhibition with respect to co-substrate in presence of 3o. The kinetics data 
strongly suggested that 3o inhibited the AlkB repair activity by competing with the 
DNA substrate binding and indirectly affected 2OG catalysis. 
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Figure 25: The effect of increasing concentrations of compound 3o over the rate of 
reaction of AlkB shown in Lineweaver-Burk plot of steady-state kinetics. Reactions 
were analyzed by quantification of formaldehyde released. (B) Lineweaver-Burk 
plot showing the effect of increasing concentrations of compound 3o over the rate of 
AlkB-catalyzed reaction with respect to 2OG. Error bars represent standard error 
from three independent experiments.   
4.3.4. Prediction of binding pocket 
The binding conformation of 3o and AlkB was further analyzed using molecular 
docking to predict the binding pocket. The active site Fe in AlkB is coordinated by 
the HDH triad formed by H131, D133, and H187. Single-stranded DNA is bound to 
active site via Nucleotide recognition lid formed by first 90 amino acids of the N 
terminal region. AlkB can bind to and repair many different kinds of damaged 
substrates viz. 1meA, 3meC, 1meG, etc but the binding mechanism remains the 
same for all. The damaged base is sandwiched between H131 and W69 by 
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hydrophobic interactions. Also, D135 forms a Hydrogen bond with the N6 position 
of 1-meA. 
The target methylene group is bound by R210 via Vander wall interaction. 
The methylated nucleotide is recognized by the interaction of R161 with the 
phosphate of damaged nucleotide by the formation of a salt bridge. The nucleotide 
backbone of the substrate DNA is stabilized in Nucleotide recognition lid (NRL) via 
hydrogen bonding between phosphate groups and T51, Y76 and R161. Y76 plays an 
important role in DNA binding by hydrogen bonding network, providing 
hydrophobic interaction for base stacking and hydroxyl side chains interact with the 
phosphodiester backbone thus stabilizing the DNA. K127 and S129 also help in 
stabilizing phosphodiester backbone of DNA. Y55 interacts with the ribose sugar via 
hydrophobic interactions. 2OG is coordinated by binding motif R204xNxTxR210 
which is conserved. C5 carboxylate of 2OG interacts with Arg204 by salt bridge 
formation and forms a hydrogen bond with N206 and Y122. The oxygen from C1 
carboxylate group of 2OG forms hydrogen bond with N120 and R210 [10] . The 
docking data showed that compound 3o interacted with AlkB by binding to the 
active site and blocking DNA binding. Compound 3o formed direct pi-cation/anion 
interactions with the H131, D133 which are part of active site triad. Compound 3o 
also formed a hydrogen bond with R210 which binds to the methylated nucleotide. 
These interactions were possibly inhibiting the binding of the damaged base as the 
key residues involved in substrate recognition and binding are obstructed. 
Compound 3o also formed pi-pi stacking and pi- sigma stacking with Trp69 which 
is essential for catalysis. 3o also blocked the nucleotide recognition lid (NRL) by 
forming pi-alkyl stacking with Met57 and Tyr76 which essentially provide 
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flexibility and interaction platform for accommodating DNA backbone [11, 12] (Fig. 
26).  
4.3.5. Inhibition of AlkB by 3o significantly enhances MMS-induces cell death 
 E. coli Alkb mutant strain (HK82), lacking functional AlkB is sensitive to MMS 
and fails to grow in media containing 0.01% MMS [13]. Based on these findings, it 
was hypothesized that the presence of a chemical inhibitor of AlkB will also cause 
normal cells to become sensitive to MMS and the cell survival would be inversely 
proportional to the degree of inhibition. It was examined whether the compound 3o 
can inhibit E. coli AlkB function in vivo. To determine that wild-type E. coli cells 
were inoculated in media containing 0.01% MMS. E. coli strain with mutant alkb 
(HK82) was used as a control. It was found that the growth of wild-type E. coli was 
not affected by the presence of 0.01% MMS in the culture media due to active DNA 
repair by AlkB. However, alkb mutant strain (HK82) failed to grow under the 
identical condition suggesting the importance of repair for cell viability (Fig. 27A).  
Cells were grown in the media containing MMS in presence of each compound (3a-
3q) independently and the rate of cell growth was analyzed. As shown in Figure 
27A, no other compound except 3o resulted any pronounced growth inhibition. We 
found that growth rate of wild-type E. coli in presence of 3o was slow and 
comparable to alkb mutant strain HK82 (Figure 27A). 
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Figure 26: (A) Molecular docking analysis showing potential binding pocket of 
compound 3o. (B) AlkB residues forming the binding pocket of compound 3o. 
 
Notably, compound 3n, 3p and 3j, which showed some inhibition in the in vitro 
assay, failed to exhibit any growth inhibition, suggesting that these set of 2-Chloro-
3-Amino indanone derivatives has no pleiotropic effect on the growth of E. coli. 
These results suggest that compound 3o is cell permeable and could inhibit catalytic 
activity of AlkB.  
In the subsequent experiment as shown in Fig. 27B, the E. coli cells were 
treated with increasing concentration of compound 3o. It was observed that E. coli 
cells were becoming more sensitive to MMS upon increasing 3o concentration. 
These results suggested that compound 3o is cell permeable and could inhibit the 
bacterial AlkB in vivo. AlkB is well reported to repair N-alkylation damage caused 
the SN2 type of methylating agents. MMS belongs to an SN2-type methylating agent 
that induces the formation of N1meA and N3meC lesions on DNA and repaired 
123 
 
specifically by AlkB. In summary Seventeen 2-Chloro-3-Amino indenone 
compounds were synthesized and evaluated as potential inhibitors of AlkB-
catalyzed DNA demethylation. This study revealed the ability of one of the 
compounds 3o to be competitive inhibitors of AlkB-catalyzed demethylation of 
DNA. This compound exhibited selective binding properties and was able to 
modulate the function of AlkB when present in the micromolar range of 
concentrations. 
 
Figure 27: The inhibitory effect of 3o on the in vivo repair activity. (A) Inhibition of 
repair was monitored by decreased cell survival upon exposure to compound 3a-3q 
and DNA alkylating chemical MMS. Bacterial growth of wild-type E. coli, in 
presence of 3o and the alkb mutant strain (HK82), was monitored as control. 
Compounds 3a-3q (50μM) were dissolved in DMSO and added to the E.coli cells 
growing in LB media containing 0.01% MMS. Bacterial growth was monitored by 
OD600 for 5h. The growth of cells in the absence of inhibitor was considered as 
100%. The mean value of five independent experiments is plotted.  (B) Effect of 
increasing concentration of compound 3o on bacterial growth.  
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Chapter 5: Screening and evaluation of indenone derivatives as 
potential inhibitors of human AlkBH3 
 
5.1. Introduction 
DNA methylation is an evolutionarily conserved mechanism of regulation present in 
the eukaryotic genome. DNA methylation at N-5 position of cytosine (N5meC) acts 
as epigenetic marker [1]. DNMT which is the enzyme responsible for N5meC 
methylation has also been known to methylate cytosine non-specifically at N3 
position generating N3meC lesions which are mutagenic [2]. DNMT’s have been 
found to be one of the major sources of endogenous N3meC generation in cells. In 
recent years, it has been found that DNMT’s are overexpressed in several cancers 
such as breast cancer, prostate cancer, colon cancer [3]. Overexpression of DNMT’s 
has been associated with promoting tumorigenesis in cancer cells [4]. These aberrant 
methyl adducts generated by DNMTs need to be reapaired by AlkB homologs.  
Human genome encodes nine homologues of AlkB (AlkBH1-8 and FTO) [5]. 
Human AlkB homolog-2 (AlkBH2) and AlkB homolog-3 (AlkBH3) have been 
known to repair N1meA and N3meC methylation damages in double- and single-
stranded DNA and RNA [16]. Recent studies have suggested a direct role of 
AlkBH3 in cancer cell proliferation [6-18]. It has been reported that the proliferation 
of lung and prostate cancer cells is dependent on AlkBH3 expression [14, 15]. It has 
been shown that siRNA mediated knockdown of AlkBH3 in the human lung 
adenocarcinoma cell line A549 resulted in cell cycle arrest, senescence and strong 
suppression of cell growth [15]; prostate cancer cell line LANCap and PC3 
overexpressed AlkBH3 and siRNA mediated knockdown of AlkBH3 resulted in 
reduced proliferation [19, 20]. AlkBH3 knockdown in another prostate cancer cell 
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line DU145 resulted in apoptosis [21]. Moreover, the high level of AlkBH3 
expression is also found in non–small-cell lung cancer[15], pancreatic cancer,[22] 
and renal cell carcinoma [23]. Knockdown of AlkBH3 in these cells resulted in 
reduced proliferation [20]. Since overexpression of AlkBH3 is strongly linked to 
cancer, selective inhibitors for AlkBH3 are highly desirable.  
The objective of this chapter was to test indenone derivatives for potential inhibition 
of AlkBH3. 
5.2. Materials and method 
5.2.1. Cloning 
AlkBH3 was cloned into pTYB3 vector using NcoI and SalI sites. AlkBH2 was 
cloned into pET-28-a vector using EcoRI and SalI Sites.  
Table 7: Cloning strategy for genes cloned in section 5.2.1. 
Clone Clone 
No. 
Oligo 
Sequence (5’ – 3’) 
Restriction 
sites 
pTYB3-
ABH3 
254 Abh3-Tagless_R_Sal1 
ATA AGT CGA CCC AGG GTG CCC CTC GAG GGT 
CTG G 
 
ABH3-BamH1-Nco1-sen 
CCT GGG ATC CAT GGA GGA AAA AAG ACG 
GCG AGC C 
 
 
NcoI 
SalI 
pET-
AlkBH2 
258 
 
ABH2-EcoRI-sen 
TCG AGA ATT CAT GGA CAG ATT CCT GGT GAA 
AGG GG 
 
ABH2-SalI-Anti 
CAG CGC TAG CGT CGA CTT ATT TTT TAG TAA 
GCA AAA TTT TAC G 
EcoRI 
SalI 
 
5.2.2. Purification of proteins 
Tagless AlkB, AlkBH3, and His-AlKBH2 proteins were expressed in BL-
21(DE3)plysS cells by transformation of pTYB3-AlkB, pTYB3-AlkBH3, and 
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pET28a-AlkBH2 plasmids respectively. The purification protocol followed was 
same as discussed in section 2.2.1. The purified proteins were then dialyzed in a 
buffer containing 20mM Tris pH8.0 and 300mM NaCl. 
5.2.3. Preparation of methylated DNA substrate 
Desalted oligonucleotide 40mer polydT with single C (5’ TTT TTT TTT TTT TTT 
TTT C TTT TTT TTT TTT TTT TTT TTT 3’) was purchased from Imperial 
Lifescience. Methylation adducts were generated by treating the oligonucleotide 
with MMS (Sigma, 129925). The methylation protocol was same as discusses in 
section 4.2.2. 
5.2.4. Preparation of double-stranded DNA substrate 
Double-stranded DNA substrate was prepared by annealing MMS damaged 40mer 
polydTC DNA with 40mer polyA DNA. 250ng/µL of each of polyA and polyTC 
DNA were added to the annealing buffer containing 20mM Tris-HCl pH8.0 and 
1mM EDTA. The annealing reaction was incubated at 37ºC for 30 minutes followed 
by incubation on ice for 5minutes. The annealed DNA was then aliquoted and stored 
at -86ºC. 
5.2.5. In vitro screening 
A library of indenone derivatives consisting of 27 compounds was screened for 
inhibition of AlkBH3 demethylation activity.  10mM stock of compounds was 
prepared by dissolving the desired amount in 100% DMSO. In vitro screening of 
compounds for their inhibition of demethylation activity was carried out with 
purified tag-less protein. 0.2µM of AlkBH3 was incubated with 50µM of different 
compounds dissolved in DMSO at 37°C for 1 h in demethylation reaction buffer 
(20mM Tris-HCl pH 8.0, 0.2mM 2OG, 20μM Fe(NH4)2(SO4)2, 2mM l-Ascorbate). 
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1µM of the substrate which was MMS damaged 40-mer oligonucleotide containing 
single N3meC was then added to initiate the AlkB catalyzed demethylation reaction. 
The released formaldehyde was quantified using direct repair assay as discussed 
earlier. To check the specificity of these compounds the assay was also performed 
with purified tagless AlkB and His-AlkBH2. Double-stranded DNA containing 
single N3meC (1µM) was used as a substrate for AlkBH2. 
5.2.6. Determination of IC50 
Different concentrations of indenone compounds 5a, 5b, and 5c ranging from 0.5 
µM to 1000 µM were dissolved in DMSO and added to AlkBH3 demethylation 
reaction mix. A 50µl reaction was set up with 1.5µl of 6.5µM AlkBH3 incubated in 
5µl of 10X reaction buffer (20mM Tris-HCl pH 8.0, 0.2mM 2OG, 20µM 
Fe(NH4)2(SO4)2, 2mM L-Ascorbate) and incubated at 37◦C for 60 min. The 
reaction was initiated by adding 5µl of the 10µM substrate followed by further 
incubation of 1hr at 37ºC. The total reaction volume was 50µL. The formaldehyde 
generation was determined by using fluorescence-based method for direct detection 
of formaldehyde [156] . The initial velocity Vo was measured for each reaction and 
plotted against compound concentrations in order to determine the IC50 values 
using GraphPadPrism software. 
5.2.7. CD-spectroscopy 
The protein AlkBH3 was prepared for CD experiment by dialyzing in low salt buffer 
containing 10mM Tris-HCl pH 7.4 and 50mM NaCl. The ligand compound 5c was 
diluted in DMSO to the final DMSO concentration of 0.1%. 1:1 ratio of AlkBH3 
and the compound 5c was used for the CD spectroscopy. 12µM of AlkBH3 and 
12µM of compound 5c were mixed in assay buffer comprising 10mM Tris-HCl, pH 
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7.4 and 50mM NaCl at room temperature. CD spectra were recorded for both far UV 
CD in the wavelength range of 190nm to 160nm and near UV CD in the wavelength 
range of 240-360nm using a 1mm path length quartz cell. AlkBH3 (12µM) and the 
compound 5c (12µM) was mixed 1:1 molar ratio for 1h. CD spectra were also 
recorded for the protein AlkBH3 and compound 5c individually. Since the 
compounds were dissolved in DMSO, it was added in all the three samples ie. 
AlkBH3/compound5c/AlkBH3+compound 5c to the final concentration of 0.1%. 
CD spectroscopy was done using JASCO J-1500 instrument. The CD parameters 
were kept same as described in section 4.2.5. 
5.2.8. Isothermal titration calorimetry (ITC)  
 ITC was done using Microcal 200 (GE Healthcare). The sample cell was filled with 
Purified AlkBH3 10µM and the compound 5c was added to the syringe at the 
concentration of 100µM. The experiments were carried out with 20 consecutive 
injections (2µl) of compound 5c (100µM) to mix with the AlkBH3 (10µM) with 2 
min intervals between successive injections. The rotation speed of the syringe was 
maintained at 600 rpm. The integration of the heat pulses obtained from each 
titration was fitted using MicroCal Origin 7.0 software to determine the site-binding 
model and to obtain the corresponding dissociation constant. 
5.2.9. Enzyme kinetics 
 Purified recombinant AlkBH3 (0.2µM) was mixed with the eight different 
concentration of 40-mer internal N3me-oligo-dC (ranging from 0.12-3.8µM) in 
reaction buffer (20mM Tris-HCl pH 8.0, 0.2mM 2OG, 20µM Fe(NH4)2(SO4)2, 
2mM L-Ascorbate). Reactions were also performed in presence of 50, 100, 250 and 
500µM of compound 5c. The enzyme was mixed with compounds for 1h and the 
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reaction started by adding the substrate. The amount of formaldehyde released at 
different time point was quantified using direct repair assay where formaldehyde 
released was detected by converting it into a fluorescent product. The initial 
velocities after addition of the compounds were calculated by the analysis of the 
slopes of time course reactions. The initial velocity data were then fit to the 
Michaelis-Menten equation to calculate Vmax (maximal velocity), KM (Michaelis 
constant) using GraphPad Prism 7.0 (GraphPad Software, Inc., San Diego, CA). 
Transformation of Michaelis-Menten to Lineweaver-Burk plot was also carried out 
by GraphPad Prism 7.0. 
 
5.2.10. Molecular docking 
Autodock-4.0 was used for docking 5c, 5b and 5a to and AlkBH3 using structure 
2IUW from protein data bank. 3D structure of the ligands was prepared using the 
MarvinSketch software. The geometry optimization and energy minimization of 
ligands were carried out using an MM94 force field. The protein structure was 
prepared by adding Hydrogen atoms followed by removal of all the water 
molecules, using Autodock-4.0. Kollman charges were added to protein prior to 
docking using Autodock tools. The compounds 5a, 5b, and 5c were docked to 
AlkBH3 blindly using the grid box of dimensions 126×126×126 with grid box 
center at (14.268, 3.335, −7.861) and spacing of 0.5Å. Analysis of the docked 
structures and evaluation of binding energy was done using analysis tool of 
Autodock suite. Visualization of the docked structure of protein-ligand and 
comparison of the docked positions of different ligands was done using Discovery 
studio visualizer. 
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5.2.11.  Cytotoxicity analysis 
For analysis of toxicity of the indenone compounds, A549 cells were studied. A549 
cell line is non-small cell lung cancer cell line derived from Human 
adenocarcinoma. Mice model studies have shown that siRNA mediated knockdown 
of AlkBH3 in A549 cell line leads to cell cycle arrest and suppression of cell growth 
[15]. Cells were seeded in 96 well plates (2000 cells/well) and cultured in DMEM 
media (Himedia cat. No. AL219A) supplemented with 10% v/v fetal bovine serum 
(Genetix brand cat.No. CCS-500-SA-U) and incubated overnight at 37°C, 5% CO2. 
A range of concentration (0.01–200 μM) of compounds 5a/5b/5c was added in four 
replicates to the cells in 96-well plate and incubated at 37°C, 5% CO2 for 48–72 h. 
After the incubation period, cells viability was analyzed using the MTT assay. MTT 
assay was done using EZcount MTT cell assay kit, Himedia. For MTT assay, first, 
the media was removed from the wells of 96-well plate. The cells were then washed 
with PBS twice and 100uL of colorless DMEM media (Himedia cat no. AL264A). 
10µL of MTT reagent was added to the wells and plate was incubated in dark at 
37°C, 5% CO2 for 4 hours. After the incubation period, 100µL of solubilization 
solution was added to the plate and it was incubated on a gyratory shaker for 
15mins. The absorbance was measured at 570nm using Multimode reader, Biotek 
Instrument. 
 
5.2.12. Effect of AlkBH3 inhibition on cell proliferation: 
The effect of inhibition of AlkBH3 on the proliferation of A549 cells was studied. 
A549 cells were seeded in 96 well plates at the density of 1000 cells/ well and 
cultured  
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Table 8. Library of 22 indenone compounds screened for AlkBH3 inhibition 
Structure Molecular weight Compound No. 
 
359.2139  
4a 
 
329.1879  
4b 
 
359.2139  
4c 
 
299.1619  
4d 
 
313.1885  
4e 
 
349.2206  
4f 
 
284.7369  
5a 
 
346.8063  
5b 
 
360.8329  
5c 
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386.4398  
6a 
 
386.4398  
6b 
 
448.5092  
7a 
 
462.5357  
7b 
 
356.4138  
8a 
 
356.4138  
8b 
 
296.3618  
8c 
 
416.1624  
8d 
 
324.4150  
8e 
 
434.1421  
8f 
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418.4832  
9a 
 
478.1780  
9b 
 
358.1358  
9c 
 
418.4832  
9d 
 
432.5098  
10a 
 
492.5617  
10b 
 
354.0255  
13 
 
363.45 14 
 
388.4557  
15 
 
in DMEM media (Himedia cat. No. AL219A) supplemented with 10% v/v fetal 
bovine serum (Genetix brand cat.No. CCS-500-SA-U). The cells were allowed to 
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adhere by overnight incubation at 37°C, 5% CO2. Then the cells were treated with 
1µM of compound 5a, 5b or 5c in presence of MMS 1mM over a period of 60 
hours. A parallel control experiment was set up where cell proliferation was 
monitored without any treatment. The cell density was determined after every 12-
hour treatment using MTT assay. The protocol for MTT assay was same as 
discussed in section 5.2.10. The resulting cell number was plotted with respect to 
time. 
5.2.13. MMS sensitivity of A549 cells 
A549 cells were seeded in 96 well plates (2000 cells/well) and cultured in DMEM 
media supplemented with 10% v/v fetal bovine serum and incubated overnight at 
37°C, 5% CO2. A549 cells were exposed to various concentrations of MMS from 0-
400µM (0, 10, 50, 100, 200, 300 and 400µM) for 48 hours. The cells were also 
treated with 1µM of compound 5a, 5b or 5c to determine the effect of AlkBH3 
inhibition on MMS sensitivity of A549 cells. After 48 hours, the cell viability at 
each MMS concentration with or without treatment with the compound was 
determined using the MTT assay.  The protocol for MTT assay was same as 
discussed in section 5.2.10. 
 
5.3. Results and discussion 
5.3.1.  Evaluation indenone compounds as an inhibitor of DNA repair by 
human AlkBH3 
In order to screen compounds for their inhibitory effect on the activity of human 
AlkBH3, a robust assay that directly monitors formaldehyde release over time was 
used. The assay is based on the reaction of acetoacetanilide with formaldehyde in 
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presence of ammonium acetate and formation of a fluorescent dihydropyridine 
derivative with peak emission at 465 nm. Formaldehyde concentration was detected 
from a standard plot of formaldehyde. To carry out in vitro DNA repair reaction, 
purified E. coli AlkB, human AlkBH2, and AlkBH3 proteins were used. 
Recombinant proteins were purified without any affinity tag. MMS-damaged 40-mer 
oligonucleotide (T20 3meC T19) consisting of single N3meC was used as the 
substrate. For the screening of compounds, confirmed it was first confirmed that the 
DMSO concentration of 10% (the final concentration used for screening) did not 
affect the AlkB or AlkBH3 activity. In vitro DNA repair reactions (50μl) were 
performed at pH 8.0 for 1 h by using a purified enzyme (0.2μM) and 40-mer oligo-
N3me-C (1μM) as substrate. All the in vitro assays were performed in parallel and 
the results were obtained with the same batch of the methylated oligonucleotide. 
Recombinant AlkB, AlkBH2, and AlkBH3 showed comparable repair as evident 
from the similar absorption at 465 nm (Fig. 28A and B). As a control to indicate no 
DNA repair reaction, catalytically dead mutant AlkB was used. In vitro screening 
was performed using 50 μM of each of the compounds. To allow binding, the 
enzyme was mixed with compounds for 1 h before adding the substrate to the 
reaction. Representative results of the initial screening are shown in Fig. 31A. A 
compound was considered to have an inhibitory effect when the measured 
formaldehyde release was less than 10% of the DMSO control. As a result of the 
initial screening of 27 compounds, three compounds, namely 5c, 8f and 10a 
displayed significant inhibitory effect on the human AlkBH3 activity. In order to 
find the selectivity of the compounds, the effect of 5c was tested on the activity of E. 
coli AlkB and human AlkBH2. As shown in Fig. 31B AlkBH3 activity was 
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significantly affected by 5c but AlkB and AlkBH2 activity remained unchanged. 
Next, the IC50 values of the compound 5c, 8f and 10a were determined in vitro. As 
shown in Fig. 32, the IC50 value of the 5c was found to 9.84 μM. Although the IC50 
values of 8f and 10a were also close, the compound with the lowest IC-50 was 
selected for further screening. 
5.3.2. Conformational and binding analysis of AlkBH3 inhibitor 5c 
The potent inhibitory activity of 5c suggested that it might directly interact with 
AlkBH3. To test this hypothesis, the ability of the compounds to form complex was 
tested by using circular dichroism (CD) spectroscopy and isothermal titration 
calorimetry (ITC). Chiral molecules exhibit CD spectra when chromophore groups 
absorb light in the specific wavelength regions. Far-UV (190–260 nm) CD 
spectroscopy of proteins is characteristic of backbone folding whereas the near-UV 
(260–310 nm) CD spectroscopy gives information about the local tertiary structure 
of the aromatic side-chain residues such as tryptophan, tyrosine and phenylalanine, 
and disulfide bonds. The far-UV CD spectra of AlkBH3 and 5c-bound AlkBH3 
revealed that the 5c binding resulted in alteration of CD signal at 195 nm, 
characteristic double-stranded β- helix conformation of AlkBH3 (Fig. 33).  This 
indicated that the conformational change induced by binding of 5c might involve 
only a few residues from a larger and structured domain, most probably the jelly roll 
fold where active site is located. near-UV CD-spectra of AlkBH3 in the presence 
and absence of 5c was also analyzed. As shown in Fig. 33, near-UV CD spectra of 
the 5c-bound AlkBH3 were different from the free protein. The compound 5c being 
achiral molecule did not exhibit any CD signal. Since AlkBH3 lack disulfide bond, 
near-UV CD spectroscopy only. 
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Figure 28: (A) Fluorescence emission spectra of recombinant AlkB, AlkBH2, 
AlkBH3 and mutant AlkB for comparing enzyme activity. (B) Bar graph 
representation of AlkB, AlkBH2, AlkBH3 and mutant AlkB activity quantified by 
measuring released formaldehyde. Error bar depicts the standard error from three 
independent experiments. 
 
Figure 29: Inhibitor screening assay 
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Figure 30: Library of 27 indenone analogs screened for inhibition of AlkBH3 
demethylation activity. 
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Figure 31: (A) screening for inhibition of AlkBH3 activity with 27 indenone (B) 
Effect of AlkBH3 inhibitor 5c on the activity of AlkB and AlkBH2. Error 
barsrepresent ± SEM (n=5). **P < 0.01; Student’s t-tests. 
B 
A 
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depicted asymmetry surrounding the aromatic residues and any associated tertiary 
structure perturbations in the microenvironment. As Shown in Fig. 33, near UV CD 
spectrum of AlkBH3- 5c indicated the variation of the chiral environment of 
aromatic amino acid residues, tryptophan (290–300 nm), tyrosine (270–280 nm) and 
phenylalanine (250–270 nm). Together, the CD spectroscopy data strongly 
suggested subtle structural changes of AlkBH3 molecule upon 5c binding. Next, the 
binding of AlkBH3 to 5c was validated by quantifying the corresponding 
thermodynamic parameters by ITC. The ITC data were fitted to a one-binding site 
model and the derived parameters are shown in Fig. 34. The data revealed that the 
binding between 5c and AlkBH3 were tight (Kd=7.81 μM) and binding resulted in 
an unfavorable entropy change (ΔS < 0) and a favorable enthalpy change (ΔH < 0). 
ΔS and ΔH both being negative signified favorable non-covalent interactions, 
including electrostatic, H-bonding and van der Waals interactions between the 
AlkB/AlkBH3 protein and the compound. 
 
5.3.3. Mechanism of inhibition of AlkBH3 
Steady-state enzyme kinetics was performed to study the mechanism of inhibition of 
the compounds. For this, the initial velocity of AlkBH3 was determined in the 
presence of increasing concentrations (50–500 μM) of compound 5c. The variable 
concentration of substrate and fixed saturating concentration of co-substrate 2OG 
(200 μM) was used. The initial velocities of AlkBH3 in presence of increasing 
concentration of compound 5c resulted in unchanged Vmax, a feature characteristic 
of competitive inhibitor (Fig. 35A). It was speculated that 5c might bind close to the 
catalytic site of AlkBH3. The initial velocities of AlkBH3 were also analyzed by the 
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variable concentration of co-substrate (2OG) and fixed saturating concentration of 
substrate DNA (1.5 μM) and increasing concentration of 5c. As shown in Fig. 35B, 
with AlkBH3 and a variable concentration of 2OG, Lineweaver-Burk plot revealed a 
concomitant decrease of Vmax with increasing concentration of 5c and the 
intersection of the lines were above the y-axis, which suggested the compound 5c to 
be mixed type inhibitor with respect to 2OG cosubstrate. Such mixed-type inhibition 
against 2OG substrate of AlkBH3 by 5c might be indicated that these compounds 
bind to a site different from the 2OG-binding site and thus influence the binding of 
2OG by indirect competition. Taken together, these results provided evidence that 
indenone- derived compound 5c can inhibit DNA repair activity by directly 
competing with the substrate binding and indirectly affecting 2OG binding. 
To gain further insight into the mechanism of 5c, the binding efficiency of 5c to the 
target molecule AlkBH3 was analysed by molecular docking studies.  Notably, 5c 
differs structurally from 5a and 5b by an aromatic ring and methyl group, 
respectively. The docking analysis demonstrated that 5c forms pi-sigma bond with 
His 191, which is part of the active site iron coordination triad that forms the 
characteristic HD…H motif. The carbonyl group of 5c makes hydrogen bond with 
Arg131 via side chain amino group of present at a distance of 3.10 Å. It also 
interacts with Arg 131 via pi-cation bonding. Interestingly, Arg 131 is important for 
binding of in-coming damaged 
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Figure 32: IC50 data of compounds 5a, 5b and 5c against AlkBH3 
 
 
 
Figure 33: Conformational analysis of AlkBH3-5c interaction by circular dichroism 
(CD). Far-UV CD spectra (between 190 nm and 260 nm) for AlkBH3 or AlkbH3 
with compound 5c bound; near-UV CD spectra (between 240 nm and 360 nm) for 
AlkBH3 
 
base to the pocket. 5c also interacts with Tyr 143 by pi-pi stacking and Arg 275 by 
pi-cation interaction. Agr275 is involved in 2OG binding via coordination with C1 
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of 2OG. Overall, most of the 5c interacting residues are of catalytic importance to 
AlkBH3. Mutational studies have shown that point mutation of any of these of 
residues makes AlkBH3 inactive [25]. On the other hand, docking analysis of 5b 
showed that it interacts with Tyr 143 by forming pi-pi stacking but unlike 5c, it does 
not interfere with either the DNA binding residues or the 2OG coordination 
residues. Similarly, docking analysis of 5a showed that it binds to a different 
location further away from the DNA binding pocket via interaction with Ile 203. 
Taken together, molecular docking analysis revealed structure-activity relationship 
of AlkBH3 inhibition by 5c and suggested that binding of 5c to the close proximity 
of the active site might affect the catalytic activity of AlkBH3. 3d-Graphical 
representation of docked position of 5c, 5b and 5a on AlkBH3 molecule is shown in 
Fig. 36. The ligand binding residues for compound 5c, 5b and 5c and the bonds 
formed between these molecules and amino acid residues from AlkBH3 are shown 
2d-diagram in Fig. 37. 
5.3.4. Compound 5c inhibits proliferation of human lung carcinoma A549 cells 
in a dose-dependent manner and sensitizes to alkylating agent MMS 
Human AlkBH3 is overexpressed in non-small cell lung adenocarcinoma cell line 
A549 and AlkBH3 gene silencing was reported to inhibit A549 cell survival. In 
order to test if 5c can affect the viability of A549 cell line under the culture 
condition, these cells were examined in the presence of increasing concentration of 
5c using the MTT assay. It was evident that higher concentrations of 5c in the 
culture medium inhibited the viability of A549 cells in a dose-dependent manner 
(Fig. 38). The concentration of 5c to inhibit 50% cell growth (EC50) was estimated 
to be around 18.7 μM. Since 5c is structurally similar to 5a and 5b, cell viability was 
146 
 
also tested in the presence of 5a and 5b. EC50 of 5b was much larger than 5c (369.7 
μM). A similar result was also obtained with compound 5a, which did not show any 
sensitivity even at 500 μM . Based on this result, it was concluded that only 5c could 
affect the A549 cell viability and 5a and 5b, though structurally similar, had much 
less effect on cell viability. Next, the effect of AlkBH3 inhibition on cell 
proliferation was studied. It was found that exposure to low concentration of 5c is 
sufficient to significantly suppress cell growth (Fig. 39).  
As expected, compound 5b and 5a had no effect on cell proliferation. AlkBH3-
deficient primary MEFs (mouse embryonic fibroblasts) are at least twice as sensitive 
to SN2-type alkylating agents MMS compared to wild-type MEFs. The objective 
was to see if 5c can potentiate the cytotoxic effect of the mono-functional alkylating 
agent MMS. MMS is a classic SN2 type alkylating compound which produces 
mainly N-alkylated base damage and AlkBH3 protects from MMS-induced 
cytotoxicity. It was found that 5c treatment significantly increased MMS sensitivity 
compared to the control (DMSO) in A549 cell (Fig. 40). On the contrary, compound 
5b and 5a did not cause any MMS sensitivity. Collectively, the result demonstrated 
that 5c prevented the growth of lung cancer cell line A549 and enhanced sensitivity 
to alkylating agent MMS. Although AlkBH3 knock-down was reported to inhibit 
A549 cell proliferation,3,9 it remains unclear whether the growth inhibition is 
directly due to defect of AlkBH3-mediated DNA repair. As AlkBH2-mediated DNA  
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Figure 34: Binding analysis of AlkBH3-5c 
by isothermal titration calorimetry (ITC). 
Binding of compound 5c to recombinant 
AlkBH3. The top panel represents the raw 
data from the titration as a series of peaks 
corresponding to the heat change (μ 
calories/s) with each injection. The bottom 
panel is a plot of heat change on ligand 
addition (kcal/mol) against the 5c/AlkBH3 
Molar ratio. 
 
 
Figure 35: Mechanism of catalytic inhibition. (A) The effect of increasing 
concentrations of compound 5c over the rate of reaction of AlkBH3. (B) The effect 
of increasing concentrations of compound 5c over the rate of AlkBH3- catalyzed 
reaction with respect to 2OG. Error bars represent standard error from three 
independent experiments. 
148 
 
repair remains unaltered, it can be speculated that some unique DNA damage 
signaling pathway operates in A549 cells that causes inhibition of cell proliferation. 
Therefore, attributing the MMS sensitivity of A549 cells solely toAlkBH3 inhibition 
may not be accurate. Furthermore, 5c might also have pleiotropic effects and target 
some DNA damage response pathways or AlkB homologues in living cells as the 
specific functions of these homologues are not completely understood. Several 
indenone compounds were evaluated as potential inhibitors of AlkBH3 catalyzed 
DNA demethylation. The primary screens, based on in vitro inhibition of the 
demethylase activity of AlkBH3 using single-base methylated DNA substrate and 
purified enzyme, resulted in one inhibitor against human AlkBH3. The compound 
5c exhibited modest binding properties and was able to inhibit the function of 
AlkBH3 in vitro. Addition of 5c also abrogated lung cancer cell line A549 growth 
and enhanced sensitivity to DNA alkylating agent MMS in the micromolar range of 
concentrations. Determining the precise mechanism of the inhibitors will require 
further investigation, including solving the structure with the inhibitors. The 
multitude of reports implicating AlkBH3 activity to the proliferation of cancer cells 
reflects the need for potent and selective inhibitors of AlkBH3 so that its 
pathobiology can be further explored and validated. 
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Figure 36: Molecular docking of 5a, 5b, 5c on AlkBH3. (A) Molecular docking 
analysis showing potential binding pockets of 5a, 5b and 5c. (B) Molecular docking 
analysis showing potential interactions of 5c. (C) Molecular docking to show 
relative position of 5b and 5c with respect to Tyr 143 of AlkBH3. 
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Figure 37: 2D interaction diagram of docked conformation showing interaction 
diagram of (A) 5c (B) 5b (C) 5a with AlkBH3. 
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Figure 38: (A) cytotoxic/cytostatic effect of 5c, (B) 5b, (C) 5a, respectively, 
evaluated by MTT assay. A549 cells were plated into 96-well plates, and cultured 
for 48–72 h in varying concentrations (0–200 μM) of compounds. 
A 
B 
C 
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Figure 39: Inhibition of A549 cell growth by 5c (A), 5b (B) 5a (c), respectively, 
during a time course. 12 h after seeding, the cells were exposed for two doubling 
time continuously to the fixed concentrations (1 μM) of compounds. Each bar 
represents results of four independent experiments. 
A 
B 
C 
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Figure 40:  A549 cells were exposed to MMS at various concentrations (0, 10, 50, 
100, 200, 300 and 400 μM) for 48 h; then cell viability was evaluated by MTT 
assay. Error bar represent the SEM of replicates from four representative experiment 
that was repeated two times. *P < 0.05; **P < 0.01; Student’s t-tests, ns, not 
significant. 
A 
C 
B 
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There were a few other limitations of this study. Firstly, the results were presented 
based on a small set of compounds. Further synthetic efforts are required to validate 
the SAR of this compound. Secondly, IC50 of the compound 5c was estimated to be 
9.8 μM. Although this is close to known AlkBH3 inhibitor Rhein (5.3 μM), future 
efforts will be directed to obtain a compound with sub-micromolar IC50. The fact 
that at least one hit had been found out of 27 compounds, suggests that indenone 
derivatives could provide a platform for generating inhibitor against Fe(II)/2OG-
dependent dioxygenases. It could be anticipated that these compounds might provide 
a framework from which second-generation indenone derivatives may be developed. 
The future challenge includes the development of a more potent indenone-derived 
AlkBH3 inhibitor, which may be exploited as a combination therapy for cancer 
treatment. These results might also help in finding potential pharmaceutical 
applications of indenone derivatives as inhibitors of other human 2OG/Fe(II)-
dependent oxygenase and overcoming resistance to alkylating agents used in cancer 
therapy. 
 
 
 
 
 
 
 
 
 
155 
 
5.4. References 
1. Moore, Lisa D et al. “DNA methylation and its basic 
function” Neuropsychopharmacology : official publication of the American 
College of Neuropsychopharmacology vol. 38,1 (2012): 23-38. 
2. Rošić, Silvana et al. “Evolutionary analysis indicates that DNA alkylation 
damage is a byproduct of cytosine DNA methyltransferase activity” Nature 
genetics vol. 50,3 (2018): 452-459. 
3. Subramaniam, Dharmalingam et al. “DNA methyltransferases: a novel target 
for prevention and therapy” Frontiers in oncology vol. 4 80. 2014, 
doi:10.3389/fonc.2014.00080 
4. Zhang and Xu Biomarker Research (2017) 5:1 DOI 10.1186/s40364-017-
0081-z 
5. Falnes, P.Ø., et al., Substrate specificities of bacterial and human AlkB 
proteins. Nucleic acids research, 2004. 32(11): p. 3456-3461. 
6. Cetica, V., et al., Pediatric brain tumors: mutations of two dioxygenases 
(hABH2 and hABH3) that directly repair alkylation damage. Journal of 
neuro-oncology, 2009. 94(2): p. 195-201. 
7. Choi, S.-y., J.H. Jang, and K.R. Kim, Analysis of differentially expressed 
genes in human rectal carcinoma using suppression subtractive 
hybridization. Clinical and experimental medicine, 2011. 11(4): p. 219-226. 
8. Kogaki, T., et al., TP53 gene status is a critical determinant of phenotypes 
induced by ALKBH3 knockdown in non-small cell lung cancers. Biochemical 
and biophysical research communications, 2017. 488(2): p. 285-290. 
156 
 
9. Koike, K., et al., anti-tumor effect of AlkB homolog 3 knockdown in 
hormone-independent prostate cancer cells. 2012. 12(7): p. 847-856. 
10. Konishi, N., et al., High expression of a new marker PCA-1 in human 
prostate carcinoma. 2005. 11(14): p. 5090-5097. 
11. Liefke, R., et al., The oxidative demethylase ALKBH3 marks hyperactive 
gene promoters in human cancer cells. Genome medicine, 2015. 7(1): p. 66. 
12. Müller, R., et al., Targeting proliferating cell nuclear antigen and its protein 
interactions induces apoptosis in multiple myeloma cells. PloS one, 2013. 
8(7): p. e70430. 
13. Shimada, K., et al., ALKBH3 contributes to survival and angiogenesis of 
human urothelial carcinoma cells through NADPH oxidase and 
tweak/Fn14/VEGF signals. Clinical Cancer Research, 2012: p. 5247-5255. 
14. Shimada, K., et al., Prostate cancer antigen‐1 contributes to cell survival 
and invasion though discoidin receptor 1 in human prostate cancer. 2008. 
99(1): p. 39-45. 
15. Tasaki, M., et al., ALKBH3, a human AlkB homologue, contributes to cell 
survival in human non-small-cell lung cancer. British journal of cancer, 
2011. 104(4): p. 700-706. 
16. Ueda, M., et al., Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has 
Potent Antiproliferative Effects on DU145 Cells In Vivo. Anticancer 
research, 2018. 38(1): p. 211-218. 
17. Wang, Q., et al., Association of AlkB homolog 3 expression with tumor 
recurrence and unfavorable prognosis in hepatocellular carcinoma. Journal 
of gastroenterology and hepatology, 2018. doi: 10.1111/jgh.14117. 
157 
 
18. Yamato, I., et al., PCA-1/ALKBH3 contributes to pancreatic cancer by 
supporting apoptotic resistance and angiogenesis. 2012: 72 p.4829-4839. 
19. Dango, S., et al., DNA unwinding by ASCC3 helicase is coupled to ALKBH3-
dependent DNA alkylation repair and cancer cell proliferation. Molecular 
cell, 2011. 44(3): p. 373-384. 
20. Ueda, Y., et al., AlkB homolog 3-mediated tRNA demethylation promotes 
protein synthesis in cancer cells. Scientific reports, 2017. 7: 42271. 
21. Koike, K., et al., anti-tumor effect of AlkB homolog 3 knockdown in 
hormone-independent prostate cancer cells. Current cancer drug targets, 
2012. 12(7): p. 847-856. 
22. Hotta, K., et al., Clinical significance and therapeutic potential of prostate 
cancer antigen-1/ALKBH3 in human renal cell carcinoma. Oncology 
reports, 2015. 34(2): p. 648-654. 
23. Shivange, G., et al., A role for Saccharomyces cerevisiae Tpa1 protein in 
direct alkylation repair. 2014, 289: p. 3389-97. 
24. Sundheim, O., et al., Human ABH3 structure and key residues for oxidative 
demethylation to reverse DNA/RNA damage. 2006. 25(14): p. 3389-3397. 
 
 
 
 
 
 
 
158 
 
List of publications 
 
1. Richa Nigam, Roy Anindya. Escherichia coli single-stranded DNA binding 
protein SSB promotes AlkB-mediated DNA dealkylation repair, Biochemical 
and Biophysical Research Communications (2018), 496, (2), 274-279. 
Doi:10.1016/j.bbrc.2018.01.043 
2. Richa Nigam, Monisha Mohan, Gururaj Shivange, Pranjal Kuamr 
Dewangan, Roy Anindya, Escherichia coli AlkB interacts with single-
stranded DNA binding protein SSB by an intrinsically disordered region of 
SSB, Molecular Biology Reports (2018). Doi:10.1007/s11033-018-4232-6 
3. Richa Nigam, Kaki Raveendra Babu, Topi Ghosh, Bhavini Kumari, Deepa 
Akula, Subha Narayan Rath, Prolay Das, Roy Anindya, Faiz Ahmed Khan, 
Indenone derivatives as inhibitor of human DNA dealkylation repair nzyme 
AlkBH3, Bioorganic & Medicinal Chemistry (2018),26, (14), 4100-4112, 
Doi: 10.1016/j.bmc.2018.06.040  
4. Richa Nigam, Monisha Mohan, Roy Anindya, Escherichia coli single-
stranded DNA binding protein SSB binds to AlkB and promotes DNA 
repair. FEBS Open Bio, 8: 28135 .  Doi:10.1002/2211-5463.12453 
5. Gururaj Shivange, Monisha Mohan, Richa Nigam, Naveena Kodipelli, Roy 
Anindya,  RecA stimulates AlkB-mediated direct repair of DNA 
adducts, Nucleic Acids Research,  (2016), 44, (18), 8754-8763. 
Doi:10.1093/nar/gkw611. 
 
